id	sid	tid	token	lemma	pos
cord-270934-vzsdvrwo	1	1	key	key	NN
cord-270934-vzsdvrwo	1	2	:	:	:
cord-270934-vzsdvrwo	1	3	cord-270934-vzsdvrwo	cord-270934-vzsdvrwo	ADD
cord-270934-vzsdvrwo	2	1	authors	author	NNS
cord-270934-vzsdvrwo	2	2	:	:	:
cord-270934-vzsdvrwo	2	3	Raza	Raza	NNP
cord-270934-vzsdvrwo	2	4	,	,	,
cord-270934-vzsdvrwo	2	5	Azra	Azra	NNP
cord-270934-vzsdvrwo	2	6	;	;	:
cord-270934-vzsdvrwo	2	7	Assal	Assal	NNP
cord-270934-vzsdvrwo	2	8	,	,	,
cord-270934-vzsdvrwo	2	9	Amer	Amer	NNP
cord-270934-vzsdvrwo	2	10	;	;	:
cord-270934-vzsdvrwo	2	11	Ali	Ali	NNP
cord-270934-vzsdvrwo	2	12	,	,	,
cord-270934-vzsdvrwo	2	13	Abdullah	Abdullah	NNP
cord-270934-vzsdvrwo	2	14	M.	M.	NNP
cord-270934-vzsdvrwo	2	15	;	;	:
cord-270934-vzsdvrwo	2	16	Jurcic	Jurcic	NNP
cord-270934-vzsdvrwo	2	17	,	,	,
cord-270934-vzsdvrwo	2	18	Joseph	Joseph	NNP
cord-270934-vzsdvrwo	2	19	G.	G.	NNP
cord-270934-vzsdvrwo	2	20	title	title	NN
cord-270934-vzsdvrwo	2	21	:	:	:
cord-270934-vzsdvrwo	2	22	Rewriting	rewrite	VBG
cord-270934-vzsdvrwo	2	23	the	the	DT
cord-270934-vzsdvrwo	2	24	rules	rule	NNS
cord-270934-vzsdvrwo	2	25	for	for	IN
cord-270934-vzsdvrwo	2	26	care	care	NN
cord-270934-vzsdvrwo	2	27	of	of	IN
cord-270934-vzsdvrwo	2	28	MDS	MDS	NNP
cord-270934-vzsdvrwo	2	29	and	and	CC
cord-270934-vzsdvrwo	2	30	AML	AML	NNP
cord-270934-vzsdvrwo	2	31	patients	patient	NNS
cord-270934-vzsdvrwo	2	32	in	in	IN
cord-270934-vzsdvrwo	2	33	the	the	DT
cord-270934-vzsdvrwo	2	34	time	time	NN
cord-270934-vzsdvrwo	2	35	of	of	IN
cord-270934-vzsdvrwo	2	36	COVID-19	covid-19	CD
cord-270934-vzsdvrwo	2	37	date	date	NN
cord-270934-vzsdvrwo	2	38	:	:	:
cord-270934-vzsdvrwo	2	39	2020	2020	CD
cord-270934-vzsdvrwo	2	40	-	-	HYPH
cord-270934-vzsdvrwo	2	41	04	04	CD
cord-270934-vzsdvrwo	2	42	-	-	SYM
cord-270934-vzsdvrwo	2	43	20	20	CD
cord-270934-vzsdvrwo	2	44	journal	journal	NN
cord-270934-vzsdvrwo	2	45	:	:	:
cord-270934-vzsdvrwo	3	1	Leuk	Leuk	NNP
cord-270934-vzsdvrwo	3	2	Res	Res	NNP
cord-270934-vzsdvrwo	3	3	Rep	Rep	NNP
cord-270934-vzsdvrwo	3	4	DOI	doi	NN
cord-270934-vzsdvrwo	3	5	:	:	:
cord-270934-vzsdvrwo	3	6	10.1016/	10.1016/	CD
cord-270934-vzsdvrwo	4	1	j.lrr.2020.100201	j.lrr.2020.100201	NNP
cord-270934-vzsdvrwo	4	2	sha	sha	NNP
cord-270934-vzsdvrwo	4	3	:	:	:
cord-270934-vzsdvrwo	5	1	dd2aea0face86a059933dd666822fbbcd27d9703	dd2aea0face86a059933dd666822fbbcd27d9703	NNP
cord-270934-vzsdvrwo	5	2	doc_id	doc_id	CD
cord-270934-vzsdvrwo	5	3	:	:	:
cord-270934-vzsdvrwo	5	4	270934	270934	CD
cord-270934-vzsdvrwo	5	5	cord_uid	cord_uid	NNS
cord-270934-vzsdvrwo	5	6	:	:	:
cord-270934-vzsdvrwo	5	7	vzsdvrwo	vzsdvrwo	NNP
cord-270934-vzsdvrwo	6	1	The	the	DT
cord-270934-vzsdvrwo	6	2	care	care	NN
cord-270934-vzsdvrwo	6	3	of	of	IN
cord-270934-vzsdvrwo	6	4	patients	patient	NNS
cord-270934-vzsdvrwo	6	5	with	with	IN
cord-270934-vzsdvrwo	6	6	myelodysplastic	myelodysplastic	JJ
cord-270934-vzsdvrwo	6	7	syndromes	syndrome	NNS
cord-270934-vzsdvrwo	6	8	(	(	-LRB-
cord-270934-vzsdvrwo	6	9	MDS	MDS	NNP
cord-270934-vzsdvrwo	6	10	)	)	-RRB-
cord-270934-vzsdvrwo	6	11	and	and	CC
cord-270934-vzsdvrwo	6	12	acute	acute	JJ
cord-270934-vzsdvrwo	6	13	myeloid	myeloid	NN
cord-270934-vzsdvrwo	6	14	leukemia	leukemia	NN
cord-270934-vzsdvrwo	6	15	(	(	-LRB-
cord-270934-vzsdvrwo	6	16	AML	AML	NNP
cord-270934-vzsdvrwo	6	17	)	)	-RRB-
cord-270934-vzsdvrwo	6	18	has	have	VBZ
cord-270934-vzsdvrwo	6	19	been	be	VBN
cord-270934-vzsdvrwo	6	20	radically	radically	RB
cord-270934-vzsdvrwo	6	21	altered	alter	VBN
cord-270934-vzsdvrwo	6	22	by	by	IN
cord-270934-vzsdvrwo	6	23	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	6	24	,	,	,
cord-270934-vzsdvrwo	6	25	especially	especially	RB
cord-270934-vzsdvrwo	6	26	in	in	IN
cord-270934-vzsdvrwo	6	27	New	New	NNP
cord-270934-vzsdvrwo	6	28	York	York	NNP
cord-270934-vzsdvrwo	6	29	City	City	NNP
cord-270934-vzsdvrwo	6	30	,	,	,
cord-270934-vzsdvrwo	6	31	the	the	DT
cord-270934-vzsdvrwo	6	32	epicenter	epicenter	NN
cord-270934-vzsdvrwo	6	33	of	of	IN
cord-270934-vzsdvrwo	6	34	the	the	DT
cord-270934-vzsdvrwo	6	35	pandemic	pandemic	NN
cord-270934-vzsdvrwo	6	36	.	.	.
cord-270934-vzsdvrwo	7	1	Here	here	RB
cord-270934-vzsdvrwo	7	2	we	-PRON-	PRP
cord-270934-vzsdvrwo	7	3	summarize	summarize	VBP
cord-270934-vzsdvrwo	7	4	how	how	WRB
cord-270934-vzsdvrwo	7	5	telemedicine	telemedicine	NN
cord-270934-vzsdvrwo	7	6	,	,	,
cord-270934-vzsdvrwo	7	7	virtual	virtual	JJ
cord-270934-vzsdvrwo	7	8	visits	visit	NNS
cord-270934-vzsdvrwo	7	9	,	,	,
cord-270934-vzsdvrwo	7	10	delayed	delay	VBN
cord-270934-vzsdvrwo	7	11	transfusions	transfusion	NNS
cord-270934-vzsdvrwo	7	12	,	,	,
cord-270934-vzsdvrwo	7	13	and	and	CC
cord-270934-vzsdvrwo	7	14	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	7	15	,	,	,
cord-270934-vzsdvrwo	7	16	preferably	preferably	RB
cord-270934-vzsdvrwo	7	17	selecting	select	VBG
cord-270934-vzsdvrwo	7	18	self	self	NN
cord-270934-vzsdvrwo	7	19	-	-	HYPH
cord-270934-vzsdvrwo	7	20	administered	administer	VBN
cord-270934-vzsdvrwo	7	21	medications	medication	NNS
cord-270934-vzsdvrwo	7	22	and	and	CC
cord-270934-vzsdvrwo	7	23	visits	visit	NNS
cord-270934-vzsdvrwo	7	24	by	by	IN
cord-270934-vzsdvrwo	7	25	home	home	NN
cord-270934-vzsdvrwo	7	26	healthcare	healthcare	NN
cord-270934-vzsdvrwo	7	27	workers	worker	NNS
cord-270934-vzsdvrwo	7	28	,	,	,
cord-270934-vzsdvrwo	7	29	are	be	VBP
cord-270934-vzsdvrwo	7	30	employed	employ	VBN
cord-270934-vzsdvrwo	7	31	to	to	TO
cord-270934-vzsdvrwo	7	32	minimize	minimize	VB
cord-270934-vzsdvrwo	7	33	exposure	exposure	NN
cord-270934-vzsdvrwo	7	34	of	of	IN
cord-270934-vzsdvrwo	7	35	our	-PRON-	PRP$
cord-270934-vzsdvrwo	7	36	high	high	JJ
cord-270934-vzsdvrwo	7	37	-	-	HYPH
cord-270934-vzsdvrwo	7	38	risk	risk	NN
cord-270934-vzsdvrwo	7	39	population	population	NN
cord-270934-vzsdvrwo	7	40	of	of	IN
cord-270934-vzsdvrwo	7	41	patients	patient	NNS
cord-270934-vzsdvrwo	7	42	to	to	IN
cord-270934-vzsdvrwo	7	43	the	the	DT
cord-270934-vzsdvrwo	7	44	virus	virus	NN
cord-270934-vzsdvrwo	7	45	.	.	.
cord-270934-vzsdvrwo	8	1	The	the	DT
cord-270934-vzsdvrwo	8	2	unique	unique	JJ
cord-270934-vzsdvrwo	8	3	challenges	challenge	NNS
cord-270934-vzsdvrwo	8	4	of	of	IN
cord-270934-vzsdvrwo	8	5	transplants	transplant	NNS
cord-270934-vzsdvrwo	8	6	during	during	IN
cord-270934-vzsdvrwo	8	7	the	the	DT
cord-270934-vzsdvrwo	8	8	pandemic	pandemic	NN
cord-270934-vzsdvrwo	8	9	and	and	CC
cord-270934-vzsdvrwo	8	10	the	the	DT
cord-270934-vzsdvrwo	8	11	consequences	consequence	NNS
cord-270934-vzsdvrwo	8	12	of	of	IN
cord-270934-vzsdvrwo	8	13	an	an	DT
cord-270934-vzsdvrwo	8	14	abrupt	abrupt	JJ
cord-270934-vzsdvrwo	8	15	halt	halt	NN
cord-270934-vzsdvrwo	8	16	in	in	IN
cord-270934-vzsdvrwo	8	17	all	all	DT
cord-270934-vzsdvrwo	8	18	non	non	JJ
cord-270934-vzsdvrwo	8	19	-	-	JJ
cord-270934-vzsdvrwo	8	20	essential	essential	JJ
cord-270934-vzsdvrwo	8	21	research	research	NN
cord-270934-vzsdvrwo	8	22	activities	activity	NNS
cord-270934-vzsdvrwo	8	23	are	be	VBP
cord-270934-vzsdvrwo	8	24	described	describe	VBN
cord-270934-vzsdvrwo	8	25	.	.	.
cord-270934-vzsdvrwo	9	1	Not	not	RB
cord-270934-vzsdvrwo	9	2	all	all	PDT
cord-270934-vzsdvrwo	9	3	the	the	DT
cord-270934-vzsdvrwo	9	4	changes	change	NNS
cord-270934-vzsdvrwo	9	5	forced	force	VBN
cord-270934-vzsdvrwo	9	6	by	by	IN
cord-270934-vzsdvrwo	9	7	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	9	8	are	be	VBP
cord-270934-vzsdvrwo	9	9	detrimental	detrimental	JJ
cord-270934-vzsdvrwo	9	10	.	.	.
cord-270934-vzsdvrwo	10	1	Azra	Azra	NNP
cord-270934-vzsdvrwo	10	2	Raza	Raza	NNP
cord-270934-vzsdvrwo	10	3	1,2,3	1,2,3	CD
cord-270934-vzsdvrwo	10	4	,	,	,
cord-270934-vzsdvrwo	10	5	Amer	Amer	NNP
cord-270934-vzsdvrwo	10	6	Assal	Assal	NNP
cord-270934-vzsdvrwo	10	7	1,2,3	1,2,3	CD
cord-270934-vzsdvrwo	10	8	,	,	,
cord-270934-vzsdvrwo	11	1	Abdullah	Abdullah	NNP
cord-270934-vzsdvrwo	11	2	M.	M.	NNP
cord-270934-vzsdvrwo	11	3	Ali	Ali	NNP
cord-270934-vzsdvrwo	11	4	1,2	1,2	CD
cord-270934-vzsdvrwo	11	5	,	,	,
cord-270934-vzsdvrwo	12	1	The	the	DT
cord-270934-vzsdvrwo	12	2	care	care	NN
cord-270934-vzsdvrwo	12	3	of	of	IN
cord-270934-vzsdvrwo	12	4	patients	patient	NNS
cord-270934-vzsdvrwo	12	5	with	with	IN
cord-270934-vzsdvrwo	12	6	myelodysplastic	myelodysplastic	JJ
cord-270934-vzsdvrwo	12	7	syndromes	syndrome	NNS
cord-270934-vzsdvrwo	12	8	(	(	-LRB-
cord-270934-vzsdvrwo	12	9	MDS	MDS	NNP
cord-270934-vzsdvrwo	12	10	)	)	-RRB-
cord-270934-vzsdvrwo	12	11	and	and	CC
cord-270934-vzsdvrwo	12	12	acute	acute	JJ
cord-270934-vzsdvrwo	12	13	myeloid	myeloid	NN
cord-270934-vzsdvrwo	12	14	leukemia	leukemia	NN
cord-270934-vzsdvrwo	12	15	(	(	-LRB-
cord-270934-vzsdvrwo	12	16	AML	AML	NNP
cord-270934-vzsdvrwo	12	17	)	)	-RRB-
cord-270934-vzsdvrwo	12	18	has	have	VBZ
cord-270934-vzsdvrwo	12	19	been	be	VBN
cord-270934-vzsdvrwo	12	20	radically	radically	RB
cord-270934-vzsdvrwo	12	21	altered	alter	VBN
cord-270934-vzsdvrwo	12	22	by	by	IN
cord-270934-vzsdvrwo	12	23	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	12	24	,	,	,
cord-270934-vzsdvrwo	12	25	especially	especially	RB
cord-270934-vzsdvrwo	12	26	in	in	IN
cord-270934-vzsdvrwo	12	27	New	New	NNP
cord-270934-vzsdvrwo	12	28	York	York	NNP
cord-270934-vzsdvrwo	12	29	City	City	NNP
cord-270934-vzsdvrwo	12	30	,	,	,
cord-270934-vzsdvrwo	12	31	the	the	DT
cord-270934-vzsdvrwo	12	32	epicenter	epicenter	NN
cord-270934-vzsdvrwo	12	33	of	of	IN
cord-270934-vzsdvrwo	12	34	the	the	DT
cord-270934-vzsdvrwo	12	35	pandemic	pandemic	NN
cord-270934-vzsdvrwo	12	36	.	.	.
cord-270934-vzsdvrwo	13	1	Here	here	RB
cord-270934-vzsdvrwo	13	2	we	-PRON-	PRP
cord-270934-vzsdvrwo	13	3	summarize	summarize	VBP
cord-270934-vzsdvrwo	13	4	how	how	WRB
cord-270934-vzsdvrwo	13	5	telemedicine	telemedicine	NN
cord-270934-vzsdvrwo	13	6	,	,	,
cord-270934-vzsdvrwo	13	7	virtual	virtual	JJ
cord-270934-vzsdvrwo	13	8	visits	visit	NNS
cord-270934-vzsdvrwo	13	9	,	,	,
cord-270934-vzsdvrwo	13	10	delayed	delay	VBN
cord-270934-vzsdvrwo	13	11	transfusions	transfusion	NNS
cord-270934-vzsdvrwo	13	12	,	,	,
cord-270934-vzsdvrwo	13	13	and	and	CC
cord-270934-vzsdvrwo	13	14	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	13	15	,	,	,
cord-270934-vzsdvrwo	13	16	preferably	preferably	RB
cord-270934-vzsdvrwo	13	17	selecting	select	VBG
cord-270934-vzsdvrwo	13	18	self	self	NN
cord-270934-vzsdvrwo	13	19	-	-	HYPH
cord-270934-vzsdvrwo	13	20	administered	administer	VBN
cord-270934-vzsdvrwo	13	21	medications	medication	NNS
cord-270934-vzsdvrwo	13	22	and	and	CC
cord-270934-vzsdvrwo	13	23	visits	visit	NNS
cord-270934-vzsdvrwo	13	24	by	by	IN
cord-270934-vzsdvrwo	13	25	home	home	NN
cord-270934-vzsdvrwo	13	26	healthcare	healthcare	NN
cord-270934-vzsdvrwo	13	27	workers	worker	NNS
cord-270934-vzsdvrwo	13	28	,	,	,
cord-270934-vzsdvrwo	13	29	are	be	VBP
cord-270934-vzsdvrwo	13	30	employed	employ	VBN
cord-270934-vzsdvrwo	13	31	to	to	TO
cord-270934-vzsdvrwo	13	32	minimize	minimize	VB
cord-270934-vzsdvrwo	13	33	exposure	exposure	NN
cord-270934-vzsdvrwo	13	34	of	of	IN
cord-270934-vzsdvrwo	13	35	our	-PRON-	PRP$
cord-270934-vzsdvrwo	13	36	high	high	JJ
cord-270934-vzsdvrwo	13	37	-	-	HYPH
cord-270934-vzsdvrwo	13	38	risk	risk	NN
cord-270934-vzsdvrwo	13	39	population	population	NN
cord-270934-vzsdvrwo	13	40	of	of	IN
cord-270934-vzsdvrwo	13	41	patients	patient	NNS
cord-270934-vzsdvrwo	13	42	to	to	IN
cord-270934-vzsdvrwo	13	43	the	the	DT
cord-270934-vzsdvrwo	13	44	virus	virus	NN
cord-270934-vzsdvrwo	13	45	.	.	.
cord-270934-vzsdvrwo	14	1	The	the	DT
cord-270934-vzsdvrwo	14	2	unique	unique	JJ
cord-270934-vzsdvrwo	14	3	challenges	challenge	NNS
cord-270934-vzsdvrwo	14	4	of	of	IN
cord-270934-vzsdvrwo	14	5	transplants	transplant	NNS
cord-270934-vzsdvrwo	14	6	during	during	IN
cord-270934-vzsdvrwo	14	7	the	the	DT
cord-270934-vzsdvrwo	14	8	pandemic	pandemic	NN
cord-270934-vzsdvrwo	14	9	and	and	CC
cord-270934-vzsdvrwo	14	10	the	the	DT
cord-270934-vzsdvrwo	14	11	consequences	consequence	NNS
cord-270934-vzsdvrwo	14	12	of	of	IN
cord-270934-vzsdvrwo	14	13	an	an	DT
cord-270934-vzsdvrwo	14	14	abrupt	abrupt	JJ
cord-270934-vzsdvrwo	14	15	halt	halt	NN
cord-270934-vzsdvrwo	14	16	in	in	IN
cord-270934-vzsdvrwo	14	17	all	all	DT
cord-270934-vzsdvrwo	14	18	non	non	JJ
cord-270934-vzsdvrwo	14	19	-	-	JJ
cord-270934-vzsdvrwo	14	20	essential	essential	JJ
cord-270934-vzsdvrwo	14	21	research	research	NN
cord-270934-vzsdvrwo	14	22	activities	activity	NNS
cord-270934-vzsdvrwo	14	23	are	be	VBP
cord-270934-vzsdvrwo	14	24	described	describe	VBN
cord-270934-vzsdvrwo	14	25	.	.	.
cord-270934-vzsdvrwo	15	1	Not	not	RB
cord-270934-vzsdvrwo	15	2	all	all	PDT
cord-270934-vzsdvrwo	15	3	the	the	DT
cord-270934-vzsdvrwo	15	4	changes	change	NNS
cord-270934-vzsdvrwo	15	5	forced	force	VBN
cord-270934-vzsdvrwo	15	6	by	by	IN
cord-270934-vzsdvrwo	15	7	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	15	8	are	be	VBP
cord-270934-vzsdvrwo	15	9	detrimental	detrimental	JJ
cord-270934-vzsdvrwo	15	10	.	.	.
cord-270934-vzsdvrwo	16	1	Main	main	JJ
cord-270934-vzsdvrwo	16	2	text	text	NN
cord-270934-vzsdvrwo	17	1	:	:	:
cord-270934-vzsdvrwo	17	2	A	a	DT
cord-270934-vzsdvrwo	17	3	tiny	tiny	JJ
cord-270934-vzsdvrwo	17	4	piece	piece	NN
cord-270934-vzsdvrwo	17	5	of	of	IN
cord-270934-vzsdvrwo	17	6	RNA	RNA	NNP
cord-270934-vzsdvrwo	17	7	has	have	VBZ
cord-270934-vzsdvrwo	17	8	altered	alter	VBN
cord-270934-vzsdvrwo	17	9	the	the	DT
cord-270934-vzsdvrwo	17	10	practice	practice	NN
cord-270934-vzsdvrwo	17	11	of	of	IN
cord-270934-vzsdvrwo	17	12	medicine	medicine	NN
cord-270934-vzsdvrwo	17	13	overnight	overnight	RB
cord-270934-vzsdvrwo	17	14	.	.	.
cord-270934-vzsdvrwo	18	1	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	18	2	impacts	impact	NNS
cord-270934-vzsdvrwo	18	3	every	every	DT
cord-270934-vzsdvrwo	18	4	aspect	aspect	NN
cord-270934-vzsdvrwo	18	5	of	of	IN
cord-270934-vzsdvrwo	18	6	care	care	NN
cord-270934-vzsdvrwo	18	7	for	for	IN
cord-270934-vzsdvrwo	18	8	patients	patient	NNS
cord-270934-vzsdvrwo	18	9	with	with	IN
cord-270934-vzsdvrwo	18	10	myelodysplastic	myelodysplastic	JJ
cord-270934-vzsdvrwo	18	11	syndromes	syndrome	NNS
cord-270934-vzsdvrwo	18	12	(	(	-LRB-
cord-270934-vzsdvrwo	18	13	MDS	MDS	NNP
cord-270934-vzsdvrwo	18	14	)	)	-RRB-
cord-270934-vzsdvrwo	18	15	and	and	CC
cord-270934-vzsdvrwo	18	16	acute	acute	JJ
cord-270934-vzsdvrwo	18	17	myeloid	myeloid	NN
cord-270934-vzsdvrwo	18	18	leukemia	leukemia	NN
cord-270934-vzsdvrwo	18	19	(	(	-LRB-
cord-270934-vzsdvrwo	18	20	AML	AML	NNP
cord-270934-vzsdvrwo	18	21	)	)	-RRB-
cord-270934-vzsdvrwo	18	22	in	in	IN
cord-270934-vzsdvrwo	18	23	the	the	DT
cord-270934-vzsdvrwo	18	24	City	City	NNP
cord-270934-vzsdvrwo	18	25	of	of	IN
cord-270934-vzsdvrwo	18	26	New	New	NNP
cord-270934-vzsdvrwo	18	27	York	York	NNP
cord-270934-vzsdvrwo	19	1	from	from	IN
cord-270934-vzsdvrwo	19	2	where	where	WRB
cord-270934-vzsdvrwo	19	3	we	-PRON-	PRP
cord-270934-vzsdvrwo	19	4	are	be	VBP
cord-270934-vzsdvrwo	19	5	writing	write	VBG
cord-270934-vzsdvrwo	19	6	,	,	,
cord-270934-vzsdvrwo	19	7	our	-PRON-	PRP$
cord-270934-vzsdvrwo	19	8	hospital	hospital	NN
cord-270934-vzsdvrwo	19	9	is	be	VBZ
cord-270934-vzsdvrwo	19	10	serving	serve	VBG
cord-270934-vzsdvrwo	19	11	as	as	IN
cord-270934-vzsdvrwo	19	12	the	the	DT
cord-270934-vzsdvrwo	19	13	epicenter	epicenter	NN
cord-270934-vzsdvrwo	19	14	of	of	IN
cord-270934-vzsdvrwo	19	15	the	the	DT
cord-270934-vzsdvrwo	19	16	pandemic	pandemic	NN
cord-270934-vzsdvrwo	19	17	within	within	IN
cord-270934-vzsdvrwo	19	18	the	the	DT
cord-270934-vzsdvrwo	19	19	city	city	NN
cord-270934-vzsdvrwo	19	20	.	.	.
cord-270934-vzsdvrwo	20	1	Not	not	RB
cord-270934-vzsdvrwo	20	2	all	all	PDT
cord-270934-vzsdvrwo	20	3	the	the	DT
cord-270934-vzsdvrwo	20	4	changes	change	NNS
cord-270934-vzsdvrwo	20	5	are	be	VBP
cord-270934-vzsdvrwo	20	6	unwelcome	unwelcome	JJ
cord-270934-vzsdvrwo	20	7	.	.	.
cord-270934-vzsdvrwo	21	1	For	for	IN
cord-270934-vzsdvrwo	21	2	one	one	CD
cord-270934-vzsdvrwo	21	3	thing	thing	NN
cord-270934-vzsdvrwo	21	4	,	,	,
cord-270934-vzsdvrwo	21	5	the	the	DT
cord-270934-vzsdvrwo	21	6	importance	importance	NN
cord-270934-vzsdvrwo	21	7	of	of	IN
cord-270934-vzsdvrwo	21	8	the	the	DT
cord-270934-vzsdvrwo	21	9	patient	patient	NN
cord-270934-vzsdvrwo	21	10	over	over	IN
cord-270934-vzsdvrwo	21	11	paperwork	paperwork	NN
cord-270934-vzsdvrwo	21	12	is	be	VBZ
cord-270934-vzsdvrwo	21	13	re	re	VBG
cord-270934-vzsdvrwo	21	14	-	-	VBN
cord-270934-vzsdvrwo	21	15	established	establish	VBN
cord-270934-vzsdvrwo	21	16	.	.	.
cord-270934-vzsdvrwo	22	1	For	for	IN
cord-270934-vzsdvrwo	22	2	another	another	DT
cord-270934-vzsdvrwo	22	3	,	,	,
cord-270934-vzsdvrwo	22	4	caregivers	caregiver	NNS
cord-270934-vzsdvrwo	22	5	are	be	VBP
cord-270934-vzsdvrwo	22	6	visiting	visit	VBG
cord-270934-vzsdvrwo	22	7	a	a	DT
cord-270934-vzsdvrwo	22	8	majority	majority	NN
cord-270934-vzsdvrwo	22	9	of	of	IN
cord-270934-vzsdvrwo	22	10	patients	patient	NNS
cord-270934-vzsdvrwo	22	11	in	in	IN
cord-270934-vzsdvrwo	22	12	the	the	DT
cord-270934-vzsdvrwo	22	13	comfort	comfort	NN
cord-270934-vzsdvrwo	22	14	of	of	IN
cord-270934-vzsdvrwo	22	15	their	-PRON-	PRP$
cord-270934-vzsdvrwo	22	16	homes	home	NNS
cord-270934-vzsdvrwo	22	17	,	,	,
cord-270934-vzsdvrwo	22	18	a	a	DT
cord-270934-vzsdvrwo	22	19	move	move	NN
cord-270934-vzsdvrwo	22	20	appreciated	appreciate	VBN
cord-270934-vzsdvrwo	22	21	by	by	IN
cord-270934-vzsdvrwo	22	22	patients	patient	NNS
cord-270934-vzsdvrwo	22	23	while	while	IN
cord-270934-vzsdvrwo	22	24	the	the	DT
cord-270934-vzsdvrwo	22	25	pandemic	pandemic	NN
cord-270934-vzsdvrwo	22	26	rages	rage	VBZ
cord-270934-vzsdvrwo	22	27	on	on	RP
cord-270934-vzsdvrwo	22	28	and	and	CC
cord-270934-vzsdvrwo	22	29	fears	fear	NNS
cord-270934-vzsdvrwo	22	30	of	of	IN
cord-270934-vzsdvrwo	22	31	infection	infection	NN
cord-270934-vzsdvrwo	22	32	are	be	VBP
cord-270934-vzsdvrwo	22	33	high	high	JJ
cord-270934-vzsdvrwo	22	34	.	.	.
cord-270934-vzsdvrwo	23	1	Health	health	NN
cord-270934-vzsdvrwo	23	2	care	care	NN
cord-270934-vzsdvrwo	23	3	professionals	professional	NNS
cord-270934-vzsdvrwo	23	4	for	for	IN
cord-270934-vzsdvrwo	23	5	their	-PRON-	PRP$
cord-270934-vzsdvrwo	23	6	part	part	NN
cord-270934-vzsdvrwo	23	7	have	have	VBP
cord-270934-vzsdvrwo	23	8	successfully	successfully	RB
cord-270934-vzsdvrwo	23	9	adapted	adapt	VBN
cord-270934-vzsdvrwo	23	10	to	to	IN
cord-270934-vzsdvrwo	23	11	virtual	virtual	JJ
cord-270934-vzsdvrwo	23	12	visits	visit	NNS
cord-270934-vzsdvrwo	23	13	and	and	CC
cord-270934-vzsdvrwo	23	14	new	new	JJ
cord-270934-vzsdvrwo	23	15	ways	way	NNS
cord-270934-vzsdvrwo	23	16	of	of	IN
cord-270934-vzsdvrwo	23	17	remote	remote	JJ
cord-270934-vzsdvrwo	23	18	billing	billing	NN
cord-270934-vzsdvrwo	23	19	,	,	,
cord-270934-vzsdvrwo	23	20	following	follow	VBG
cord-270934-vzsdvrwo	23	21	often	often	RB
cord-270934-vzsdvrwo	23	22	repetitive	repetitive	JJ
cord-270934-vzsdvrwo	23	23	and	and	CC
cord-270934-vzsdvrwo	23	24	frustrating	frustrating	JJ
cord-270934-vzsdvrwo	23	25	re	re	NN
cord-270934-vzsdvrwo	23	26	-	-	JJ
cord-270934-vzsdvrwo	23	27	training	training	NN
cord-270934-vzsdvrwo	23	28	classes	class	NNS
cord-270934-vzsdvrwo	23	29	.	.	.
cord-270934-vzsdvrwo	24	1	Thanks	thank	NNS
cord-270934-vzsdvrwo	24	2	to	to	IN
cord-270934-vzsdvrwo	24	3	electronic	electronic	JJ
cord-270934-vzsdvrwo	24	4	health	health	NN
cord-270934-vzsdvrwo	24	5	records	record	NNS
cord-270934-vzsdvrwo	24	6	,	,	,
cord-270934-vzsdvrwo	24	7	care	care	NN
cord-270934-vzsdvrwo	24	8	of	of	IN
cord-270934-vzsdvrwo	24	9	patients	patient	NNS
cord-270934-vzsdvrwo	24	10	continues	continue	VBZ
cord-270934-vzsdvrwo	24	11	uninterrupted	uninterrupted	JJ
cord-270934-vzsdvrwo	24	12	as	as	IN
cord-270934-vzsdvrwo	24	13	providers	provider	NNS
cord-270934-vzsdvrwo	24	14	work	work	VBP
cord-270934-vzsdvrwo	24	15	from	from	IN
cord-270934-vzsdvrwo	24	16	home	home	NN
cord-270934-vzsdvrwo	24	17	.	.	.
cord-270934-vzsdvrwo	25	1	As	as	IN
cord-270934-vzsdvrwo	25	2	select	select	JJ
cord-270934-vzsdvrwo	25	3	benefits	benefit	NNS
cord-270934-vzsdvrwo	25	4	of	of	IN
cord-270934-vzsdvrwo	25	5	the	the	DT
cord-270934-vzsdvrwo	25	6	new	new	JJ
cord-270934-vzsdvrwo	25	7	approaches	approach	NNS
cord-270934-vzsdvrwo	25	8	dawn	dawn	NN
cord-270934-vzsdvrwo	25	9	upon	upon	IN
cord-270934-vzsdvrwo	25	10	the	the	DT
cord-270934-vzsdvrwo	25	11	participants	participant	NNS
cord-270934-vzsdvrwo	25	12	,	,	,
cord-270934-vzsdvrwo	25	13	it	-PRON-	PRP
cord-270934-vzsdvrwo	25	14	is	be	VBZ
cord-270934-vzsdvrwo	25	15	unlikely	unlikely	JJ
cord-270934-vzsdvrwo	25	16	we	-PRON-	PRP
cord-270934-vzsdvrwo	25	17	will	will	MD
cord-270934-vzsdvrwo	25	18	return	return	VB
cord-270934-vzsdvrwo	25	19	precisely	precisely	RB
cord-270934-vzsdvrwo	25	20	to	to	IN
cord-270934-vzsdvrwo	25	21	the	the	DT
cord-270934-vzsdvrwo	25	22	pre	pre	JJ
cord-270934-vzsdvrwo	25	23	-	-	JJ
cord-270934-vzsdvrwo	25	24	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	25	25	days	day	NNS
cord-270934-vzsdvrwo	25	26	.	.	.
cord-270934-vzsdvrwo	26	1	Nor	nor	CC
cord-270934-vzsdvrwo	26	2	should	should	MD
cord-270934-vzsdvrwo	26	3	we	-PRON-	PRP
cord-270934-vzsdvrwo	26	4	.	.	.
cord-270934-vzsdvrwo	27	1	There	there	EX
cord-270934-vzsdvrwo	27	2	is	be	VBZ
cord-270934-vzsdvrwo	27	3	no	no	DT
cord-270934-vzsdvrwo	27	4	inherent	inherent	JJ
cord-270934-vzsdvrwo	27	5	righteousness	righteousness	NN
cord-270934-vzsdvrwo	27	6	in	in	IN
cord-270934-vzsdvrwo	27	7	the	the	DT
cord-270934-vzsdvrwo	27	8	way	way	NN
cord-270934-vzsdvrwo	27	9	things	thing	NNS
cord-270934-vzsdvrwo	27	10	were	be	VBD
cord-270934-vzsdvrwo	27	11	done	do	VBN
cord-270934-vzsdvrwo	27	12	.	.	.
cord-270934-vzsdvrwo	28	1	This	this	DT
cord-270934-vzsdvrwo	28	2	communication	communication	NN
cord-270934-vzsdvrwo	28	3	summarizes	summarize	VBZ
cord-270934-vzsdvrwo	28	4	the	the	DT
cord-270934-vzsdvrwo	28	5	immediate	immediate	JJ
cord-270934-vzsdvrwo	28	6	changes	change	NNS
cord-270934-vzsdvrwo	28	7	in	in	IN
cord-270934-vzsdvrwo	28	8	how	how	WRB
cord-270934-vzsdvrwo	28	9	we	-PRON-	PRP
cord-270934-vzsdvrwo	28	10	care	care	VBP
cord-270934-vzsdvrwo	28	11	for	for	IN
cord-270934-vzsdvrwo	28	12	our	-PRON-	PRP$
cord-270934-vzsdvrwo	28	13	MDS	MDS	NNP
cord-270934-vzsdvrwo	28	14	and	and	CC
cord-270934-vzsdvrwo	28	15	AML	AML	NNP
cord-270934-vzsdvrwo	28	16	patients	patient	NNS
cord-270934-vzsdvrwo	28	17	during	during	IN
cord-270934-vzsdvrwo	28	18	the	the	DT
cord-270934-vzsdvrwo	28	19	pandemic	pandemic	NN
cord-270934-vzsdvrwo	28	20	.	.	.
cord-270934-vzsdvrwo	29	1	Weighing	weigh	VBG
cord-270934-vzsdvrwo	29	2	the	the	DT
cord-270934-vzsdvrwo	29	3	risks	risk	NNS
cord-270934-vzsdvrwo	29	4	of	of	IN
cord-270934-vzsdvrwo	29	5	bringing	bring	VBG
cord-270934-vzsdvrwo	29	6	patients	patient	NNS
cord-270934-vzsdvrwo	29	7	to	to	IN
cord-270934-vzsdvrwo	29	8	a	a	DT
cord-270934-vzsdvrwo	29	9	hospital	hospital	NN
cord-270934-vzsdvrwo	29	10	filled	fill	VBN
cord-270934-vzsdvrwo	29	11	with	with	IN
cord-270934-vzsdvrwo	29	12	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	29	13	patients	patient	NNS
cord-270934-vzsdvrwo	29	14	is	be	VBZ
cord-270934-vzsdvrwo	29	15	forcing	force	VBG
cord-270934-vzsdvrwo	29	16	an	an	DT
cord-270934-vzsdvrwo	29	17	examination	examination	NN
cord-270934-vzsdvrwo	29	18	of	of	IN
cord-270934-vzsdvrwo	29	19	what	what	WP
cord-270934-vzsdvrwo	29	20	can	can	MD
cord-270934-vzsdvrwo	29	21	be	be	VB
cord-270934-vzsdvrwo	29	22	achieved	achieve	VBN
cord-270934-vzsdvrwo	29	23	remotely	remotely	RB
cord-270934-vzsdvrwo	29	24	.	.	.
cord-270934-vzsdvrwo	30	1	Sending	send	VBG
cord-270934-vzsdvrwo	30	2	home	home	NN
cord-270934-vzsdvrwo	30	3	healthcare	healthcare	NN
cord-270934-vzsdvrwo	30	4	workers	worker	NNS
cord-270934-vzsdvrwo	30	5	to	to	TO
cord-270934-vzsdvrwo	30	6	check	check	VB
cord-270934-vzsdvrwo	30	7	vital	vital	JJ
cord-270934-vzsdvrwo	30	8	signs	sign	NNS
cord-270934-vzsdvrwo	30	9	and	and	CC
cord-270934-vzsdvrwo	30	10	obtain	obtain	VB
cord-270934-vzsdvrwo	30	11	blood	blood	NN
cord-270934-vzsdvrwo	30	12	tests	test	NNS
cord-270934-vzsdvrwo	30	13	to	to	TO
cord-270934-vzsdvrwo	30	14	determine	determine	VB
cord-270934-vzsdvrwo	30	15	what	what	WP
cord-270934-vzsdvrwo	30	16	,	,	,
cord-270934-vzsdvrwo	30	17	if	if	IN
cord-270934-vzsdvrwo	30	18	any	any	DT
cord-270934-vzsdvrwo	30	19	,	,	,
cord-270934-vzsdvrwo	30	20	treatments	treatment	NNS
cord-270934-vzsdvrwo	30	21	or	or	CC
cord-270934-vzsdvrwo	30	22	supportive	supportive	JJ
cord-270934-vzsdvrwo	30	23	care	care	NN
cord-270934-vzsdvrwo	30	24	measures	measure	NNS
cord-270934-vzsdvrwo	30	25	are	be	VBP
cord-270934-vzsdvrwo	30	26	needed	need	VBN
cord-270934-vzsdvrwo	30	27	is	be	VBZ
cord-270934-vzsdvrwo	30	28	one	one	CD
cord-270934-vzsdvrwo	30	29	important	important	JJ
cord-270934-vzsdvrwo	30	30	step	step	NN
cord-270934-vzsdvrwo	30	31	.	.	.
cord-270934-vzsdvrwo	31	1	Switching	switch	VBG
cord-270934-vzsdvrwo	31	2	therapies	therapy	NNS
cord-270934-vzsdvrwo	31	3	that	that	WDT
cord-270934-vzsdvrwo	31	4	can	can	MD
cord-270934-vzsdvrwo	31	5	be	be	VB
cord-270934-vzsdvrwo	31	6	self	self	NN
cord-270934-vzsdvrwo	31	7	-	-	HYPH
cord-270934-vzsdvrwo	31	8	administered	administer	VBN
cord-270934-vzsdvrwo	31	9	is	be	VBZ
cord-270934-vzsdvrwo	31	10	another	another	DT
cord-270934-vzsdvrwo	31	11	.	.	.
cord-270934-vzsdvrwo	32	1	For	for	IN
cord-270934-vzsdvrwo	32	2	example	example	NN
cord-270934-vzsdvrwo	32	3	,	,	,
cord-270934-vzsdvrwo	32	4	lowerrisk	lowerrisk	NNP
cord-270934-vzsdvrwo	32	5	MDS	MDS	NNP
cord-270934-vzsdvrwo	32	6	patients	patient	NNS
cord-270934-vzsdvrwo	32	7	with	with	IN
cord-270934-vzsdvrwo	32	8	deletion	deletion	NN
cord-270934-vzsdvrwo	32	9	5q	5q	CD
cord-270934-vzsdvrwo	32	10	presently	presently	RB
cord-270934-vzsdvrwo	32	11	maintained	maintain	VBD
cord-270934-vzsdvrwo	32	12	on	on	IN
cord-270934-vzsdvrwo	32	13	erythropoietin	erythropoietin	NN
cord-270934-vzsdvrwo	32	14	support	support	NN
cord-270934-vzsdvrwo	32	15	may	may	MD
cord-270934-vzsdvrwo	32	16	be	be	VB
cord-270934-vzsdvrwo	32	17	better	well	JJR
cord-270934-vzsdvrwo	32	18	off	off	RP
cord-270934-vzsdvrwo	32	19	either	either	CC
cord-270934-vzsdvrwo	32	20	taking	take	VBG
cord-270934-vzsdvrwo	32	21	the	the	DT
cord-270934-vzsdvrwo	32	22	injections	injection	NNS
cord-270934-vzsdvrwo	32	23	at	at	IN
cord-270934-vzsdvrwo	32	24	home	home	NN
cord-270934-vzsdvrwo	32	25	or	or	CC
cord-270934-vzsdvrwo	32	26	switching	switch	VBG
cord-270934-vzsdvrwo	32	27	to	to	IN
cord-270934-vzsdvrwo	32	28	oral	oral	JJ
cord-270934-vzsdvrwo	32	29	lenalidomide	lenalidomide	NN
cord-270934-vzsdvrwo	32	30	.	.	.
cord-270934-vzsdvrwo	33	1	[	[	-LRB-
cord-270934-vzsdvrwo	33	2	1	1	CD
cord-270934-vzsdvrwo	33	3	]	]	-RRB-
cord-270934-vzsdvrwo	33	4	Anemic	anemic	JJ
cord-270934-vzsdvrwo	33	5	patients	patient	NNS
cord-270934-vzsdvrwo	33	6	with	with	IN
cord-270934-vzsdvrwo	33	7	ring	ring	NN
cord-270934-vzsdvrwo	33	8	sideroblasts	sideroblast	NNS
cord-270934-vzsdvrwo	33	9	eligible	eligible	JJ
cord-270934-vzsdvrwo	33	10	for	for	IN
cord-270934-vzsdvrwo	33	11	therapy	therapy	NN
cord-270934-vzsdvrwo	33	12	with	with	IN
cord-270934-vzsdvrwo	33	13	luspatercept	luspatercept	NNP
cord-270934-vzsdvrwo	33	14	would	would	MD
cord-270934-vzsdvrwo	33	15	have	have	VB
cord-270934-vzsdvrwo	33	16	the	the	DT
cord-270934-vzsdvrwo	33	17	same	same	JJ
cord-270934-vzsdvrwo	33	18	choice	choice	NN
cord-270934-vzsdvrwo	33	19	.	.	.
cord-270934-vzsdvrwo	34	1	[	[	-LRB-
cord-270934-vzsdvrwo	34	2	2	2	CD
cord-270934-vzsdvrwo	34	3	]	]	-RRB-
cord-270934-vzsdvrwo	35	1	These	these	DT
cord-270934-vzsdvrwo	35	2	decisions	decision	NNS
cord-270934-vzsdvrwo	35	3	are	be	VBP
cord-270934-vzsdvrwo	35	4	reached	reach	VBN
cord-270934-vzsdvrwo	35	5	after	after	IN
cord-270934-vzsdvrwo	35	6	careful	careful	JJ
cord-270934-vzsdvrwo	35	7	discussions	discussion	NNS
cord-270934-vzsdvrwo	35	8	between	between	IN
cord-270934-vzsdvrwo	35	9	patients	patient	NNS
cord-270934-vzsdvrwo	35	10	and	and	CC
cord-270934-vzsdvrwo	35	11	caregivers	caregiver	NNS
cord-270934-vzsdvrwo	35	12	,	,	,
cord-270934-vzsdvrwo	35	13	some	some	DT
cord-270934-vzsdvrwo	35	14	electing	elect	VBG
cord-270934-vzsdvrwo	35	15	to	to	TO
cord-270934-vzsdvrwo	35	16	continue	continue	VB
cord-270934-vzsdvrwo	35	17	supportive	supportive	JJ
cord-270934-vzsdvrwo	35	18	care	care	NN
cord-270934-vzsdvrwo	35	19	measures	measure	NNS
cord-270934-vzsdvrwo	35	20	rather	rather	RB
cord-270934-vzsdvrwo	35	21	than	than	IN
cord-270934-vzsdvrwo	35	22	start	start	VB
cord-270934-vzsdvrwo	35	23	on	on	IN
cord-270934-vzsdvrwo	35	24	new	new	JJ
cord-270934-vzsdvrwo	35	25	therapies	therapy	NNS
cord-270934-vzsdvrwo	35	26	with	with	IN
cord-270934-vzsdvrwo	35	27	limited	limited	JJ
cord-270934-vzsdvrwo	35	28	early	early	JJ
cord-270934-vzsdvrwo	35	29	information	information	NN
cord-270934-vzsdvrwo	35	30	on	on	IN
cord-270934-vzsdvrwo	35	31	potential	potential	JJ
cord-270934-vzsdvrwo	35	32	side	side	NN
cord-270934-vzsdvrwo	35	33	effects	effect	NNS
cord-270934-vzsdvrwo	35	34	.	.	.
cord-270934-vzsdvrwo	36	1	Anemia	anemia	NN
cord-270934-vzsdvrwo	36	2	is	be	VBZ
cord-270934-vzsdvrwo	36	3	a	a	DT
cord-270934-vzsdvrwo	36	4	predominant	predominant	JJ
cord-270934-vzsdvrwo	36	5	issue	issue	NN
cord-270934-vzsdvrwo	36	6	for	for	IN
cord-270934-vzsdvrwo	36	7	the	the	DT
cord-270934-vzsdvrwo	36	8	majority	majority	NN
cord-270934-vzsdvrwo	36	9	of	of	IN
cord-270934-vzsdvrwo	36	10	patients	patient	NNS
cord-270934-vzsdvrwo	36	11	with	with	IN
cord-270934-vzsdvrwo	36	12	MDS	MDS	NNP
cord-270934-vzsdvrwo	36	13	.	.	.
cord-270934-vzsdvrwo	37	1	The	the	DT
cord-270934-vzsdvrwo	37	2	decision	decision	NN
cord-270934-vzsdvrwo	37	3	to	to	TO
cord-270934-vzsdvrwo	37	4	transfuse	transfuse	VB
cord-270934-vzsdvrwo	37	5	is	be	VBZ
cord-270934-vzsdvrwo	37	6	dependent	dependent	JJ
cord-270934-vzsdvrwo	37	7	on	on	IN
cord-270934-vzsdvrwo	37	8	patients	patient	NNS
cord-270934-vzsdvrwo	37	9	'	'	POS
cord-270934-vzsdvrwo	37	10	symptoms	symptom	NNS
cord-270934-vzsdvrwo	37	11	rather	rather	RB
cord-270934-vzsdvrwo	37	12	than	than	IN
cord-270934-vzsdvrwo	37	13	a	a	DT
cord-270934-vzsdvrwo	37	14	number	number	NN
cord-270934-vzsdvrwo	37	15	on	on	IN
cord-270934-vzsdvrwo	37	16	a	a	DT
cord-270934-vzsdvrwo	37	17	test	test	NN
cord-270934-vzsdvrwo	37	18	report	report	NN
cord-270934-vzsdvrwo	37	19	given	give	VBN
cord-270934-vzsdvrwo	37	20	the	the	DT
cord-270934-vzsdvrwo	37	21	predicted	predict	VBN
cord-270934-vzsdvrwo	37	22	shortage	shortage	NN
cord-270934-vzsdvrwo	37	23	of	of	IN
cord-270934-vzsdvrwo	37	24	blood	blood	NN
cord-270934-vzsdvrwo	37	25	products	product	NNS
cord-270934-vzsdvrwo	37	26	in	in	IN
cord-270934-vzsdvrwo	37	27	the	the	DT
cord-270934-vzsdvrwo	37	28	coming	come	VBG
cord-270934-vzsdvrwo	37	29	weeks	week	NNS
cord-270934-vzsdvrwo	37	30	.	.	.
cord-270934-vzsdvrwo	38	1	Many	many	JJ
cord-270934-vzsdvrwo	38	2	patients	patient	NNS
cord-270934-vzsdvrwo	38	3	are	be	VBP
cord-270934-vzsdvrwo	38	4	pushing	push	VBG
cord-270934-vzsdvrwo	38	5	the	the	DT
cord-270934-vzsdvrwo	38	6	limits	limit	NNS
cord-270934-vzsdvrwo	38	7	of	of	IN
cord-270934-vzsdvrwo	38	8	their	-PRON-	PRP$
cord-270934-vzsdvrwo	38	9	tolerability	tolerability	NN
cord-270934-vzsdvrwo	38	10	and	and	CC
cord-270934-vzsdvrwo	38	11	delaying	delay	VBG
cord-270934-vzsdvrwo	38	12	transfusions	transfusion	NNS
cord-270934-vzsdvrwo	38	13	because	because	IN
cord-270934-vzsdvrwo	38	14	of	of	IN
cord-270934-vzsdvrwo	38	15	the	the	DT
cord-270934-vzsdvrwo	38	16	risk	risk	NN
cord-270934-vzsdvrwo	38	17	involved	involve	VBN
cord-270934-vzsdvrwo	38	18	in	in	IN
cord-270934-vzsdvrwo	38	19	coming	come	VBG
cord-270934-vzsdvrwo	38	20	to	to	IN
cord-270934-vzsdvrwo	38	21	the	the	DT
cord-270934-vzsdvrwo	38	22	medical	medical	JJ
cord-270934-vzsdvrwo	38	23	center	center	NN
cord-270934-vzsdvrwo	38	24	.	.	.
cord-270934-vzsdvrwo	39	1	MDS	MDS	NNP
cord-270934-vzsdvrwo	39	2	patients	patient	NNS
cord-270934-vzsdvrwo	39	3	receiving	receive	VBG
cord-270934-vzsdvrwo	39	4	hypomethylating	hypomethylating	NN
cord-270934-vzsdvrwo	39	5	agents	agent	NNS
cord-270934-vzsdvrwo	39	6	are	be	VBP
cord-270934-vzsdvrwo	39	7	also	also	RB
cord-270934-vzsdvrwo	39	8	opting	opt	VBG
cord-270934-vzsdvrwo	39	9	to	to	TO
cord-270934-vzsdvrwo	39	10	prolong	prolong	VB
cord-270934-vzsdvrwo	39	11	intervals	interval	NNS
cord-270934-vzsdvrwo	39	12	between	between	IN
cord-270934-vzsdvrwo	39	13	cycles	cycle	NNS
cord-270934-vzsdvrwo	39	14	,	,	,
cord-270934-vzsdvrwo	39	15	especially	especially	RB
cord-270934-vzsdvrwo	39	16	if	if	IN
cord-270934-vzsdvrwo	39	17	they	-PRON-	PRP
cord-270934-vzsdvrwo	39	18	are	be	VBP
cord-270934-vzsdvrwo	39	19	beyond	beyond	IN
cord-270934-vzsdvrwo	39	20	six	six	CD
cord-270934-vzsdvrwo	39	21	months	month	NNS
cord-270934-vzsdvrwo	39	22	of	of	IN
cord-270934-vzsdvrwo	39	23	treatment	treatment	NN
cord-270934-vzsdvrwo	39	24	,	,	,
cord-270934-vzsdvrwo	39	25	at	at	IN
cord-270934-vzsdvrwo	39	26	least	least	JJS
cord-270934-vzsdvrwo	39	27	for	for	IN
cord-270934-vzsdvrwo	39	28	the	the	DT
cord-270934-vzsdvrwo	39	29	short	short	JJ
cord-270934-vzsdvrwo	39	30	term	term	NN
cord-270934-vzsdvrwo	39	31	.	.	.
cord-270934-vzsdvrwo	40	1	Protocol	protocol	NN
cord-270934-vzsdvrwo	40	2	guidelines	guideline	NNS
cord-270934-vzsdvrwo	40	3	are	be	VBP
cord-270934-vzsdvrwo	40	4	enforced	enforce	VBN
cord-270934-vzsdvrwo	40	5	as	as	RB
cord-270934-vzsdvrwo	40	6	strictly	strictly	RB
cord-270934-vzsdvrwo	40	7	as	as	IN
cord-270934-vzsdvrwo	40	8	possible	possible	JJ
cord-270934-vzsdvrwo	40	9	for	for	IN
cord-270934-vzsdvrwo	40	10	patients	patient	NNS
cord-270934-vzsdvrwo	40	11	on	on	IN
cord-270934-vzsdvrwo	40	12	experimental	experimental	JJ
cord-270934-vzsdvrwo	40	13	trials	trial	NNS
cord-270934-vzsdvrwo	40	14	,	,	,
cord-270934-vzsdvrwo	40	15	but	but	CC
cord-270934-vzsdvrwo	40	16	accrual	accrual	NN
cord-270934-vzsdvrwo	40	17	of	of	IN
cord-270934-vzsdvrwo	40	18	new	new	JJ
cord-270934-vzsdvrwo	40	19	subjects	subject	NNS
cord-270934-vzsdvrwo	40	20	is	be	VBZ
cord-270934-vzsdvrwo	40	21	restricted	restrict	VBN
cord-270934-vzsdvrwo	40	22	to	to	IN
cord-270934-vzsdvrwo	40	23	therapies	therapy	NNS
cord-270934-vzsdvrwo	40	24	offering	offer	VBG
cord-270934-vzsdvrwo	40	25	the	the	DT
cord-270934-vzsdvrwo	40	26	potential	potential	NN
cord-270934-vzsdvrwo	40	27	to	to	TO
cord-270934-vzsdvrwo	40	28	be	be	VB
cord-270934-vzsdvrwo	40	29	curative	curative	JJ
cord-270934-vzsdvrwo	40	30	or	or	CC
cord-270934-vzsdvrwo	40	31	to	to	TO
cord-270934-vzsdvrwo	40	32	prolong	prolong	VB
cord-270934-vzsdvrwo	40	33	survival	survival	NN
cord-270934-vzsdvrwo	40	34	significantly	significantly	RB
cord-270934-vzsdvrwo	40	35	.	.	.
cord-270934-vzsdvrwo	41	1	In	in	IN
cord-270934-vzsdvrwo	41	2	the	the	DT
cord-270934-vzsdvrwo	41	3	longer	long	JJR
cord-270934-vzsdvrwo	41	4	term	term	NN
cord-270934-vzsdvrwo	41	5	post	post	JJ
cord-270934-vzsdvrwo	41	6	-	-	JJ
cord-270934-vzsdvrwo	41	7	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	41	8	world	world	NN
cord-270934-vzsdvrwo	41	9	,	,	,
cord-270934-vzsdvrwo	41	10	many	many	JJ
cord-270934-vzsdvrwo	41	11	of	of	IN
cord-270934-vzsdvrwo	41	12	these	these	DT
cord-270934-vzsdvrwo	41	13	changes	change	NNS
cord-270934-vzsdvrwo	41	14	could	could	MD
cord-270934-vzsdvrwo	41	15	be	be	VB
cord-270934-vzsdvrwo	41	16	routine	routine	JJ
cord-270934-vzsdvrwo	41	17	as	as	IN
cord-270934-vzsdvrwo	41	18	benefits	benefit	NNS
cord-270934-vzsdvrwo	41	19	of	of	IN
cord-270934-vzsdvrwo	41	20	telemedicine	telemedicine	NN
cord-270934-vzsdvrwo	41	21	and	and	CC
cord-270934-vzsdvrwo	41	22	home	home	NN
cord-270934-vzsdvrwo	41	23	healthcare	healthcare	NN
cord-270934-vzsdvrwo	41	24	become	become	VBP
cord-270934-vzsdvrwo	41	25	more	more	RBR
cord-270934-vzsdvrwo	41	26	apparent	apparent	JJ
cord-270934-vzsdvrwo	41	27	and	and	CC
cord-270934-vzsdvrwo	41	28	safer	safe	JJR
cord-270934-vzsdvrwo	41	29	with	with	IN
cord-270934-vzsdvrwo	41	30	practice	practice	NN
cord-270934-vzsdvrwo	41	31	.	.	.
cord-270934-vzsdvrwo	42	1	The	the	DT
cord-270934-vzsdvrwo	42	2	physical	physical	JJ
cord-270934-vzsdvrwo	42	3	,	,	,
cord-270934-vzsdvrwo	42	4	financial	financial	JJ
cord-270934-vzsdvrwo	42	5	,	,	,
cord-270934-vzsdvrwo	42	6	and	and	CC
cord-270934-vzsdvrwo	42	7	emotional	emotional	JJ
cord-270934-vzsdvrwo	42	8	benefits	benefit	NNS
cord-270934-vzsdvrwo	42	9	of	of	IN
cord-270934-vzsdvrwo	42	10	these	these	DT
cord-270934-vzsdvrwo	42	11	radical	radical	JJ
cord-270934-vzsdvrwo	42	12	changes	change	NNS
cord-270934-vzsdvrwo	42	13	for	for	IN
cord-270934-vzsdvrwo	42	14	the	the	DT
cord-270934-vzsdvrwo	42	15	patient	patient	NN
cord-270934-vzsdvrwo	42	16	and	and	CC
cord-270934-vzsdvrwo	42	17	their	-PRON-	PRP$
cord-270934-vzsdvrwo	42	18	caregivers	caregiver	NNS
cord-270934-vzsdvrwo	42	19	are	be	VBP
cord-270934-vzsdvrwo	42	20	incalculable	incalculable	JJ
cord-270934-vzsdvrwo	42	21	.	.	.
cord-270934-vzsdvrwo	43	1	Given	give	VBN
cord-270934-vzsdvrwo	43	2	its	-PRON-	PRP$
cord-270934-vzsdvrwo	43	3	acuity	acuity	NN
cord-270934-vzsdvrwo	43	4	,	,	,
cord-270934-vzsdvrwo	43	5	treating	treat	VBG
cord-270934-vzsdvrwo	43	6	AML	AML	NNP
cord-270934-vzsdvrwo	43	7	during	during	IN
cord-270934-vzsdvrwo	43	8	the	the	DT
cord-270934-vzsdvrwo	43	9	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	43	10	pandemic	pandemic	NN
cord-270934-vzsdvrwo	43	11	poses	pose	VBZ
cord-270934-vzsdvrwo	43	12	unique	unique	JJ
cord-270934-vzsdvrwo	43	13	challenges	challenge	NNS
cord-270934-vzsdvrwo	43	14	.	.	.
cord-270934-vzsdvrwo	44	1	The	the	DT
cord-270934-vzsdvrwo	44	2	American	American	NNP
cord-270934-vzsdvrwo	44	3	Society	Society	NNP
cord-270934-vzsdvrwo	44	4	of	of	IN
cord-270934-vzsdvrwo	44	5	Hematology	Hematology	NNP
cord-270934-vzsdvrwo	44	6	has	have	VBZ
cord-270934-vzsdvrwo	44	7	offered	offer	VBN
cord-270934-vzsdvrwo	44	8	guidance	guidance	NN
cord-270934-vzsdvrwo	44	9	in	in	IN
cord-270934-vzsdvrwo	44	10	managing	manage	VBG
cord-270934-vzsdvrwo	44	11	this	this	DT
cord-270934-vzsdvrwo	44	12	difficult	difficult	JJ
cord-270934-vzsdvrwo	44	13	group	group	NN
cord-270934-vzsdvrwo	44	14	of	of	IN
cord-270934-vzsdvrwo	44	15	patients	patient	NNS
cord-270934-vzsdvrwo	44	16	.	.	.
cord-270934-vzsdvrwo	45	1	[	[	-LRB-
cord-270934-vzsdvrwo	45	2	3	3	CD
cord-270934-vzsdvrwo	45	3	]	]	-RRB-
cord-270934-vzsdvrwo	45	4	Since	since	IN
cord-270934-vzsdvrwo	45	5	many	many	JJ
cord-270934-vzsdvrwo	45	6	AML	AML	NNP
cord-270934-vzsdvrwo	45	7	patients	patient	NNS
cord-270934-vzsdvrwo	45	8	require	require	VBP
cord-270934-vzsdvrwo	45	9	emergent	emergent	JJ
cord-270934-vzsdvrwo	45	10	therapy	therapy	NN
cord-270934-vzsdvrwo	45	11	at	at	IN
cord-270934-vzsdvrwo	45	12	the	the	DT
cord-270934-vzsdvrwo	45	13	time	time	NN
cord-270934-vzsdvrwo	45	14	of	of	IN
cord-270934-vzsdvrwo	45	15	initial	initial	JJ
cord-270934-vzsdvrwo	45	16	diagnosis	diagnosis	NN
cord-270934-vzsdvrwo	45	17	,	,	,
cord-270934-vzsdvrwo	45	18	we	-PRON-	PRP
cord-270934-vzsdvrwo	45	19	continue	continue	VBP
cord-270934-vzsdvrwo	45	20	to	to	TO
cord-270934-vzsdvrwo	45	21	offer	offer	VB
cord-270934-vzsdvrwo	45	22	intensive	intensive	JJ
cord-270934-vzsdvrwo	45	23	induction	induction	NN
cord-270934-vzsdvrwo	45	24	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	45	25	with	with	IN
cord-270934-vzsdvrwo	45	26	curative	curative	JJ
cord-270934-vzsdvrwo	45	27	intent	intent	NN
cord-270934-vzsdvrwo	45	28	.	.	.
cord-270934-vzsdvrwo	46	1	Nevertheless	nevertheless	RB
cord-270934-vzsdvrwo	46	2	,	,	,
cord-270934-vzsdvrwo	46	3	we	-PRON-	PRP
cord-270934-vzsdvrwo	46	4	routinely	routinely	RB
cord-270934-vzsdvrwo	46	5	perform	perform	VBP
cord-270934-vzsdvrwo	46	6	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	46	7	testing	testing	NN
cord-270934-vzsdvrwo	46	8	prior	prior	RB
cord-270934-vzsdvrwo	46	9	to	to	IN
cord-270934-vzsdvrwo	46	10	the	the	DT
cord-270934-vzsdvrwo	46	11	start	start	NN
cord-270934-vzsdvrwo	46	12	of	of	IN
cord-270934-vzsdvrwo	46	13	induction	induction	NN
cord-270934-vzsdvrwo	46	14	.	.	.
cord-270934-vzsdvrwo	47	1	In	in	IN
cord-270934-vzsdvrwo	47	2	asymptomatic	asymptomatic	JJ
cord-270934-vzsdvrwo	47	3	patients	patient	NNS
cord-270934-vzsdvrwo	47	4	testing	test	VBG
cord-270934-vzsdvrwo	47	5	positive	positive	JJ
cord-270934-vzsdvrwo	47	6	,	,	,
cord-270934-vzsdvrwo	47	7	induction	induction	NN
cord-270934-vzsdvrwo	47	8	therapy	therapy	NN
cord-270934-vzsdvrwo	47	9	is	be	VBZ
cord-270934-vzsdvrwo	47	10	delayed	delay	VBN
cord-270934-vzsdvrwo	47	11	for	for	IN
cord-270934-vzsdvrwo	47	12	up	up	IN
cord-270934-vzsdvrwo	47	13	to	to	TO
cord-270934-vzsdvrwo	47	14	14	14	CD
cord-270934-vzsdvrwo	47	15	days	day	NNS
cord-270934-vzsdvrwo	47	16	if	if	IN
cord-270934-vzsdvrwo	47	17	feasible	feasible	JJ
cord-270934-vzsdvrwo	47	18	.	.	.
cord-270934-vzsdvrwo	48	1	In	in	IN
cord-270934-vzsdvrwo	48	2	most	most	JJS
cord-270934-vzsdvrwo	48	3	cases	case	NNS
cord-270934-vzsdvrwo	48	4	,	,	,
cord-270934-vzsdvrwo	48	5	we	-PRON-	PRP
cord-270934-vzsdvrwo	48	6	also	also	RB
cord-270934-vzsdvrwo	48	7	recommend	recommend	VBP
cord-270934-vzsdvrwo	48	8	postponing	postpone	VBG
cord-270934-vzsdvrwo	48	9	induction	induction	NN
cord-270934-vzsdvrwo	48	10	in	in	IN
cord-270934-vzsdvrwo	48	11	symptomatic	symptomatic	JJ
cord-270934-vzsdvrwo	49	1	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	49	2	patients	patient	NNS
cord-270934-vzsdvrwo	49	3	until	until	IN
cord-270934-vzsdvrwo	49	4	the	the	DT
cord-270934-vzsdvrwo	49	5	course	course	NN
cord-270934-vzsdvrwo	49	6	of	of	IN
cord-270934-vzsdvrwo	49	7	their	-PRON-	PRP$
cord-270934-vzsdvrwo	49	8	infection	infection	NN
cord-270934-vzsdvrwo	49	9	becomes	become	VBZ
cord-270934-vzsdvrwo	49	10	apparent	apparent	JJ
cord-270934-vzsdvrwo	49	11	and	and	CC
cord-270934-vzsdvrwo	49	12	patients	patient	NNS
cord-270934-vzsdvrwo	49	13	exhibit	exhibit	VBP
cord-270934-vzsdvrwo	49	14	some	some	DT
cord-270934-vzsdvrwo	49	15	signs	sign	NNS
cord-270934-vzsdvrwo	49	16	of	of	IN
cord-270934-vzsdvrwo	49	17	improvement	improvement	NN
cord-270934-vzsdvrwo	49	18	.	.	.
cord-270934-vzsdvrwo	50	1	Lower	low	JJR
cord-270934-vzsdvrwo	50	2	-	-	HYPH
cord-270934-vzsdvrwo	50	3	intensity	intensity	NN
cord-270934-vzsdvrwo	50	4	therapies	therapy	NNS
cord-270934-vzsdvrwo	50	5	such	such	JJ
cord-270934-vzsdvrwo	50	6	as	as	IN
cord-270934-vzsdvrwo	50	7	a	a	DT
cord-270934-vzsdvrwo	50	8	hypomethylating	hypomethylating	NN
cord-270934-vzsdvrwo	50	9	agent	agent	NN
cord-270934-vzsdvrwo	50	10	with	with	IN
cord-270934-vzsdvrwo	50	11	venetoclax	venetoclax	NNP
cord-270934-vzsdvrwo	50	12	may	may	MD
cord-270934-vzsdvrwo	50	13	be	be	VB
cord-270934-vzsdvrwo	50	14	safely	safely	RB
cord-270934-vzsdvrwo	50	15	given	give	VBN
cord-270934-vzsdvrwo	50	16	in	in	IN
cord-270934-vzsdvrwo	50	17	the	the	DT
cord-270934-vzsdvrwo	50	18	outpatient	outpatient	NN
cord-270934-vzsdvrwo	50	19	setting	set	VBG
cord-270934-vzsdvrwo	50	20	[	[	-LRB-
cord-270934-vzsdvrwo	50	21	4	4	CD
cord-270934-vzsdvrwo	50	22	]	]	-RRB-
cord-270934-vzsdvrwo	50	23	,	,	,
cord-270934-vzsdvrwo	50	24	thereby	thereby	RB
cord-270934-vzsdvrwo	50	25	reducing	reduce	VBG
cord-270934-vzsdvrwo	50	26	patient	patient	JJ
cord-270934-vzsdvrwo	50	27	exposure	exposure	NN
cord-270934-vzsdvrwo	50	28	to	to	IN
cord-270934-vzsdvrwo	50	29	novel	novel	JJ
cord-270934-vzsdvrwo	50	30	coronavirus	coronavirus	NN
cord-270934-vzsdvrwo	50	31	during	during	IN
cord-270934-vzsdvrwo	50	32	an	an	DT
cord-270934-vzsdvrwo	50	33	inpatient	inpatient	JJ
cord-270934-vzsdvrwo	50	34	stay	stay	NN
cord-270934-vzsdvrwo	50	35	,	,	,
cord-270934-vzsdvrwo	50	36	decreasing	decrease	VBG
cord-270934-vzsdvrwo	50	37	the	the	DT
cord-270934-vzsdvrwo	50	38	frequency	frequency	NN
cord-270934-vzsdvrwo	50	39	of	of	IN
cord-270934-vzsdvrwo	50	40	transfusion	transfusion	NN
cord-270934-vzsdvrwo	50	41	support	support	NN
cord-270934-vzsdvrwo	50	42	,	,	,
cord-270934-vzsdvrwo	50	43	and	and	CC
cord-270934-vzsdvrwo	50	44	permitting	permit	VBG
cord-270934-vzsdvrwo	50	45	use	use	NN
cord-270934-vzsdvrwo	50	46	of	of	IN
cord-270934-vzsdvrwo	50	47	inpatient	inpatient	JJ
cord-270934-vzsdvrwo	50	48	beds	bed	NNS
cord-270934-vzsdvrwo	50	49	for	for	IN
cord-270934-vzsdvrwo	50	50	severely	severely	RB
cord-270934-vzsdvrwo	50	51	ill	ill	JJ
cord-270934-vzsdvrwo	50	52	patients	patient	NNS
cord-270934-vzsdvrwo	50	53	with	with	IN
cord-270934-vzsdvrwo	50	54	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	50	55	.	.	.
cord-270934-vzsdvrwo	51	1	Similarly	similarly	RB
cord-270934-vzsdvrwo	51	2	,	,	,
cord-270934-vzsdvrwo	51	3	induction	induction	NN
cord-270934-vzsdvrwo	51	4	with	with	IN
cord-270934-vzsdvrwo	51	5	liposomal	liposomal	JJ
cord-270934-vzsdvrwo	51	6	daunorubicin	daunorubicin	NNS
cord-270934-vzsdvrwo	51	7	and	and	CC
cord-270934-vzsdvrwo	51	8	cytarabine	cytarabine	NNP
cord-270934-vzsdvrwo	51	9	can	can	MD
cord-270934-vzsdvrwo	51	10	be	be	VB
cord-270934-vzsdvrwo	51	11	administered	administer	VBN
cord-270934-vzsdvrwo	51	12	as	as	IN
cord-270934-vzsdvrwo	51	13	an	an	DT
cord-270934-vzsdvrwo	51	14	outpatient	outpatient	NN
cord-270934-vzsdvrwo	51	15	in	in	IN
cord-270934-vzsdvrwo	51	16	patients	patient	NNS
cord-270934-vzsdvrwo	51	17	with	with	IN
cord-270934-vzsdvrwo	51	18	AML	AML	NNP
cord-270934-vzsdvrwo	51	19	following	follow	VBG
cord-270934-vzsdvrwo	51	20	MDS	MDS	NNP
cord-270934-vzsdvrwo	51	21	,	,	,
cord-270934-vzsdvrwo	51	22	therapy	therapy	NN
cord-270934-vzsdvrwo	51	23	-	-	HYPH
cord-270934-vzsdvrwo	51	24	related	relate	VBN
cord-270934-vzsdvrwo	51	25	AML	AML	NNP
cord-270934-vzsdvrwo	51	26	,	,	,
cord-270934-vzsdvrwo	51	27	or	or	CC
cord-270934-vzsdvrwo	51	28	those	those	DT
cord-270934-vzsdvrwo	51	29	with	with	IN
cord-270934-vzsdvrwo	51	30	MDS	mds	NN
cord-270934-vzsdvrwo	51	31	-	-	HYPH
cord-270934-vzsdvrwo	51	32	related	relate	VBN
cord-270934-vzsdvrwo	51	33	cytogenetic	cytogenetic	JJ
cord-270934-vzsdvrwo	51	34	abnormalities	abnormality	NNS
cord-270934-vzsdvrwo	51	35	.	.	.
cord-270934-vzsdvrwo	52	1	[	[	-LRB-
cord-270934-vzsdvrwo	52	2	5	5	CD
cord-270934-vzsdvrwo	52	3	]	]	-RRB-
cord-270934-vzsdvrwo	52	4	Prophylactic	prophylactic	JJ
cord-270934-vzsdvrwo	52	5	antibacterial	antibacterial	JJ
cord-270934-vzsdvrwo	52	6	,	,	,
cord-270934-vzsdvrwo	52	7	antifungal	antifungal	JJ
cord-270934-vzsdvrwo	52	8	and	and	CC
cord-270934-vzsdvrwo	52	9	antiviral	antiviral	JJ
cord-270934-vzsdvrwo	52	10	therapy	therapy	NN
cord-270934-vzsdvrwo	52	11	is	be	VBZ
cord-270934-vzsdvrwo	52	12	recommended	recommend	VBN
cord-270934-vzsdvrwo	52	13	during	during	IN
cord-270934-vzsdvrwo	52	14	induction	induction	NN
cord-270934-vzsdvrwo	52	15	and	and	CC
cord-270934-vzsdvrwo	52	16	through	through	IN
cord-270934-vzsdvrwo	52	17	extended	extended	JJ
cord-270934-vzsdvrwo	52	18	periods	period	NNS
cord-270934-vzsdvrwo	52	19	of	of	IN
cord-270934-vzsdvrwo	52	20	neutropenia	neutropenia	NN
cord-270934-vzsdvrwo	52	21	.	.	.
cord-270934-vzsdvrwo	53	1	Consolidation	consolidation	NN
cord-270934-vzsdvrwo	53	2	with	with	IN
cord-270934-vzsdvrwo	53	3	high	high	JJ
cord-270934-vzsdvrwo	53	4	-	-	HYPH
cord-270934-vzsdvrwo	53	5	dose	dose	NN
cord-270934-vzsdvrwo	53	6	cytarabine	cytarabine	NN
cord-270934-vzsdvrwo	53	7	should	should	MD
cord-270934-vzsdvrwo	53	8	be	be	VB
cord-270934-vzsdvrwo	53	9	offered	offer	VBN
cord-270934-vzsdvrwo	53	10	to	to	IN
cord-270934-vzsdvrwo	53	11	patients	patient	NNS
cord-270934-vzsdvrwo	53	12	in	in	IN
cord-270934-vzsdvrwo	53	13	remission	remission	NN
cord-270934-vzsdvrwo	53	14	,	,	,
cord-270934-vzsdvrwo	53	15	provided	provide	VBN
cord-270934-vzsdvrwo	53	16	they	-PRON-	PRP
cord-270934-vzsdvrwo	53	17	test	test	VBP
cord-270934-vzsdvrwo	53	18	negative	negative	JJ
cord-270934-vzsdvrwo	53	19	for	for	IN
cord-270934-vzsdvrwo	53	20	COVID-19	covid-19	CD
cord-270934-vzsdvrwo	53	21	or	or	CC
cord-270934-vzsdvrwo	53	22	symptoms	symptom	NNS
cord-270934-vzsdvrwo	53	23	have	have	VBP
cord-270934-vzsdvrwo	53	24	resolved	resolve	VBN
cord-270934-vzsdvrwo	53	25	and	and	CC
cord-270934-vzsdvrwo	53	26	it	-PRON-	PRP
cord-270934-vzsdvrwo	53	27	is	be	VBZ
cord-270934-vzsdvrwo	53	28	likely	likely	JJ
cord-270934-vzsdvrwo	53	29	the	the	DT
cord-270934-vzsdvrwo	53	30	virus	virus	NN
cord-270934-vzsdvrwo	53	31	is	be	VBZ
cord-270934-vzsdvrwo	53	32	no	no	DT
cord-270934-vzsdvrwo	53	33	longer	long	RBR
cord-270934-vzsdvrwo	53	34	present	present	JJ
cord-270934-vzsdvrwo	53	35	.	.	.
cord-270934-vzsdvrwo	54	1	Based	base	VBN
cord-270934-vzsdvrwo	54	2	on	on	IN
cord-270934-vzsdvrwo	54	3	findings	finding	NNS
cord-270934-vzsdvrwo	54	4	from	from	IN
cord-270934-vzsdvrwo	54	5	the	the	DT
cord-270934-vzsdvrwo	54	6	MRC	MRC	NNP
cord-270934-vzsdvrwo	54	7	15	15	CD
cord-270934-vzsdvrwo	54	8	trial	trial	NN
cord-270934-vzsdvrwo	54	9	,	,	,
cord-270934-vzsdvrwo	54	10	lowering	lower	VBG
cord-270934-vzsdvrwo	54	11	the	the	DT
cord-270934-vzsdvrwo	54	12	dose	dose	NN
cord-270934-vzsdvrwo	54	13	of	of	IN
cord-270934-vzsdvrwo	54	14	cytarabine	cytarabine	NN
cord-270934-vzsdvrwo	54	15	from	from	IN
cord-270934-vzsdvrwo	54	16	3	3	CD
cord-270934-vzsdvrwo	54	17	gm	gm	NNP
cord-270934-vzsdvrwo	54	18	/	/	SYM
cord-270934-vzsdvrwo	54	19	m	m	NN
cord-270934-vzsdvrwo	54	20	2	2	CD
cord-270934-vzsdvrwo	54	21	to	to	IN
cord-270934-vzsdvrwo	54	22	1.5	1.5	CD
cord-270934-vzsdvrwo	54	23	gm	gm	NNP
cord-270934-vzsdvrwo	54	24	/	/	SYM
cord-270934-vzsdvrwo	54	25	m	m	NN
cord-270934-vzsdvrwo	54	26	2	2	CD
cord-270934-vzsdvrwo	54	27	could	could	MD
cord-270934-vzsdvrwo	54	28	minimize	minimize	VB
cord-270934-vzsdvrwo	54	29	the	the	DT
cord-270934-vzsdvrwo	54	30	duration	duration	NN
cord-270934-vzsdvrwo	54	31	of	of	IN
cord-270934-vzsdvrwo	54	32	myelosuppression	myelosuppression	NN
cord-270934-vzsdvrwo	54	33	without	without	IN
cord-270934-vzsdvrwo	54	34	sacrificing	sacrifice	VBG
cord-270934-vzsdvrwo	54	35	long	long	JJ
cord-270934-vzsdvrwo	54	36	-	-	HYPH
cord-270934-vzsdvrwo	54	37	term	term	NN
cord-270934-vzsdvrwo	54	38	outcomes	outcome	NNS
cord-270934-vzsdvrwo	54	39	.	.	.
cord-270934-vzsdvrwo	55	1	[	[	-LRB-
cord-270934-vzsdvrwo	55	2	6	6	CD
cord-270934-vzsdvrwo	55	3	]	]	-RRB-
cord-270934-vzsdvrwo	56	1	Moreover	moreover	RB
cord-270934-vzsdvrwo	56	2	,	,	,
cord-270934-vzsdvrwo	56	3	reducing	reduce	VBG
cord-270934-vzsdvrwo	56	4	the	the	DT
cord-270934-vzsdvrwo	56	5	number	number	NN
cord-270934-vzsdvrwo	56	6	of	of	IN
cord-270934-vzsdvrwo	56	7	cycles	cycle	NNS
cord-270934-vzsdvrwo	56	8	from	from	IN
cord-270934-vzsdvrwo	56	9	four	four	CD
cord-270934-vzsdvrwo	56	10	to	to	IN
cord-270934-vzsdvrwo	56	11	three	three	CD
cord-270934-vzsdvrwo	56	12	may	may	MD
cord-270934-vzsdvrwo	56	13	also	also	RB
cord-270934-vzsdvrwo	56	14	lower	lower	VB
cord-270934-vzsdvrwo	56	15	the	the	DT
cord-270934-vzsdvrwo	56	16	risk	risk	NN
cord-270934-vzsdvrwo	56	17	of	of	IN
cord-270934-vzsdvrwo	56	18	infection	infection	NN
cord-270934-vzsdvrwo	56	19	.	.	.
cord-270934-vzsdvrwo	57	1	[	[	-LRB-
cord-270934-vzsdvrwo	57	2	7	7	CD
cord-270934-vzsdvrwo	57	3	]	]	-RRB-
cord-270934-vzsdvrwo	57	4	Use	use	NN
cord-270934-vzsdvrwo	57	5	of	of	IN
cord-270934-vzsdvrwo	57	6	myeloid	myeloid	JJ
cord-270934-vzsdvrwo	57	7	growth	growth	NN
cord-270934-vzsdvrwo	57	8	factors	factor	NNS
cord-270934-vzsdvrwo	57	9	further	further	RB
cord-270934-vzsdvrwo	57	10	reduces	reduce	VBZ
cord-270934-vzsdvrwo	57	11	the	the	DT
cord-270934-vzsdvrwo	57	12	duration	duration	NN
cord-270934-vzsdvrwo	57	13	of	of	IN
cord-270934-vzsdvrwo	57	14	neutropenia	neutropenia	NN
cord-270934-vzsdvrwo	57	15	,	,	,
cord-270934-vzsdvrwo	57	16	the	the	DT
cord-270934-vzsdvrwo	57	17	risk	risk	NN
cord-270934-vzsdvrwo	57	18	of	of	IN
cord-270934-vzsdvrwo	57	19	infection	infection	NN
cord-270934-vzsdvrwo	57	20	,	,	,
cord-270934-vzsdvrwo	57	21	and	and	CC
cord-270934-vzsdvrwo	57	22	the	the	DT
cord-270934-vzsdvrwo	57	23	need	need	NN
cord-270934-vzsdvrwo	57	24	for	for	IN
cord-270934-vzsdvrwo	57	25	hospitalization	hospitalization	NN
cord-270934-vzsdvrwo	57	26	.	.	.
cord-270934-vzsdvrwo	58	1	Although	although	IN
cord-270934-vzsdvrwo	58	2	clinical	clinical	JJ
cord-270934-vzsdvrwo	58	3	trials	trial	NNS
cord-270934-vzsdvrwo	58	4	are	be	VBP
cord-270934-vzsdvrwo	58	5	preferred	prefer	VBN
cord-270934-vzsdvrwo	58	6	for	for	IN
cord-270934-vzsdvrwo	58	7	patients	patient	NNS
cord-270934-vzsdvrwo	58	8	with	with	IN
cord-270934-vzsdvrwo	58	9	relapsed	relapsed	JJ
cord-270934-vzsdvrwo	58	10	or	or	CC
cord-270934-vzsdvrwo	58	11	refractory	refractory	JJ
cord-270934-vzsdvrwo	58	12	AML	AML	NNP
cord-270934-vzsdvrwo	58	13	,	,	,
cord-270934-vzsdvrwo	58	14	accrual	accrual	NN
cord-270934-vzsdvrwo	58	15	to	to	IN
cord-270934-vzsdvrwo	58	16	many	many	JJ
cord-270934-vzsdvrwo	58	17	studies	study	NNS
cord-270934-vzsdvrwo	58	18	has	have	VBZ
cord-270934-vzsdvrwo	58	19	been	be	VBN
cord-270934-vzsdvrwo	58	20	halted	halt	VBN
cord-270934-vzsdvrwo	58	21	due	due	IN
cord-270934-vzsdvrwo	58	22	to	to	IN
cord-270934-vzsdvrwo	58	23	reduced	reduced	JJ
cord-270934-vzsdvrwo	58	24	resources	resource	NNS
cord-270934-vzsdvrwo	58	25	and	and	CC
cord-270934-vzsdvrwo	58	26	redeployment	redeployment	NN
cord-270934-vzsdvrwo	58	27	of	of	IN
cord-270934-vzsdvrwo	58	28	research	research	NN
cord-270934-vzsdvrwo	58	29	staff	staff	NN
cord-270934-vzsdvrwo	58	30	for	for	IN
cord-270934-vzsdvrwo	58	31	urgent	urgent	JJ
cord-270934-vzsdvrwo	58	32	clinical	clinical	JJ
cord-270934-vzsdvrwo	58	33	duties	duty	NNS
cord-270934-vzsdvrwo	58	34	.	.	.
cord-270934-vzsdvrwo	59	1	While	while	IN
cord-270934-vzsdvrwo	59	2	intensive	intensive	JJ
cord-270934-vzsdvrwo	59	3	salvage	salvage	NN
cord-270934-vzsdvrwo	59	4	regimens	regimen	NNS
cord-270934-vzsdvrwo	59	5	may	may	MD
cord-270934-vzsdvrwo	59	6	still	still	RB
cord-270934-vzsdvrwo	59	7	be	be	VB
cord-270934-vzsdvrwo	59	8	considered	consider	VBN
cord-270934-vzsdvrwo	59	9	for	for	IN
cord-270934-vzsdvrwo	59	10	these	these	DT
cord-270934-vzsdvrwo	59	11	patients	patient	NNS
cord-270934-vzsdvrwo	59	12	,	,	,
cord-270934-vzsdvrwo	59	13	we	-PRON-	PRP
cord-270934-vzsdvrwo	59	14	favor	favor	VBP
cord-270934-vzsdvrwo	59	15	outpatient	outpatient	NN
cord-270934-vzsdvrwo	59	16	treatment	treatment	NN
cord-270934-vzsdvrwo	59	17	with	with	IN
cord-270934-vzsdvrwo	59	18	an	an	DT
cord-270934-vzsdvrwo	59	19	oral	oral	JJ
cord-270934-vzsdvrwo	59	20	targeted	target	VBN
cord-270934-vzsdvrwo	59	21	agent	agent	NN
cord-270934-vzsdvrwo	59	22	if	if	IN
cord-270934-vzsdvrwo	59	23	a	a	DT
cord-270934-vzsdvrwo	59	24	mutation	mutation	NN
cord-270934-vzsdvrwo	59	25	in	in	IN
cord-270934-vzsdvrwo	59	26	FMS	FMS	NNP
cord-270934-vzsdvrwo	59	27	-	-	HYPH
cord-270934-vzsdvrwo	59	28	like	like	JJ
cord-270934-vzsdvrwo	59	29	tyrosine	tyrosine	NN
cord-270934-vzsdvrwo	59	30	kinase	kinase	NN
cord-270934-vzsdvrwo	59	31	3	3	CD
cord-270934-vzsdvrwo	59	32	(	(	-LRB-
cord-270934-vzsdvrwo	59	33	FLT3	FLT3	NNP
cord-270934-vzsdvrwo	59	34	)	)	-RRB-
cord-270934-vzsdvrwo	59	35	,	,	,
cord-270934-vzsdvrwo	59	36	isocitrate	isocitrate	JJ
cord-270934-vzsdvrwo	59	37	dehydrogenase	dehydrogenase	NN
cord-270934-vzsdvrwo	59	38	1	1	CD
cord-270934-vzsdvrwo	59	39	(	(	-LRB-
cord-270934-vzsdvrwo	59	40	IDH1	IDH1	NNP
cord-270934-vzsdvrwo	59	41	)	)	-RRB-
cord-270934-vzsdvrwo	59	42	,	,	,
cord-270934-vzsdvrwo	59	43	or	or	CC
cord-270934-vzsdvrwo	59	44	IDH2	IDH2	NNP
cord-270934-vzsdvrwo	59	45	is	be	VBZ
cord-270934-vzsdvrwo	59	46	detected	detect	VBN
cord-270934-vzsdvrwo	59	47	or	or	CC
cord-270934-vzsdvrwo	59	48	a	a	DT
cord-270934-vzsdvrwo	59	49	venetoclax	venetoclax	NN
cord-270934-vzsdvrwo	59	50	-	-	HYPH
cord-270934-vzsdvrwo	59	51	containing	contain	VBG
cord-270934-vzsdvrwo	59	52	regimen	regimen	NN
cord-270934-vzsdvrwo	59	53	.	.	.
cord-270934-vzsdvrwo	60	1	Patients	patient	NNS
cord-270934-vzsdvrwo	60	2	with	with	IN
cord-270934-vzsdvrwo	60	3	low	low	JJ
cord-270934-vzsdvrwo	60	4	-	-	HYPH
cord-270934-vzsdvrwo	60	5	risk	risk	NN
cord-270934-vzsdvrwo	60	6	acute	acute	JJ
cord-270934-vzsdvrwo	60	7	promyelocytic	promyelocytic	JJ
cord-270934-vzsdvrwo	60	8	leukemia	leukemia	NN
cord-270934-vzsdvrwo	60	9	(	(	-LRB-
cord-270934-vzsdvrwo	60	10	APL	APL	NNP
cord-270934-vzsdvrwo	60	11	)	)	-RRB-
cord-270934-vzsdvrwo	60	12	receive	receive	VBP
cord-270934-vzsdvrwo	60	13	induction	induction	NN
cord-270934-vzsdvrwo	60	14	with	with	IN
cord-270934-vzsdvrwo	60	15	all	all	RB
cord-270934-vzsdvrwo	60	16	-	-	HYPH
cord-270934-vzsdvrwo	60	17	trans	trans	NNP
cord-270934-vzsdvrwo	60	18	retinoic	retinoic	JJ
cord-270934-vzsdvrwo	60	19	acid	acid	NN
cord-270934-vzsdvrwo	60	20	(	(	-LRB-
cord-270934-vzsdvrwo	60	21	ATRA	ATRA	NNP
cord-270934-vzsdvrwo	60	22	)	)	-RRB-
cord-270934-vzsdvrwo	60	23	and	and	CC
cord-270934-vzsdvrwo	60	24	arsenic	arsenic	NN
cord-270934-vzsdvrwo	60	25	trioxide	trioxide	NN
cord-270934-vzsdvrwo	60	26	,	,	,
cord-270934-vzsdvrwo	60	27	as	as	IN
cord-270934-vzsdvrwo	60	28	this	this	DT
cord-270934-vzsdvrwo	60	29	regimen	regimen	NN
cord-270934-vzsdvrwo	60	30	is	be	VBZ
cord-270934-vzsdvrwo	60	31	associated	associate	VBN
cord-270934-vzsdvrwo	60	32	with	with	IN
cord-270934-vzsdvrwo	60	33	reduced	reduce	VBN
cord-270934-vzsdvrwo	60	34	duration	duration	NN
cord-270934-vzsdvrwo	60	35	of	of	IN
cord-270934-vzsdvrwo	60	36	myelosuppression	myelosuppression	NN
cord-270934-vzsdvrwo	60	37	and	and	CC
cord-270934-vzsdvrwo	60	38	risk	risk	NN
cord-270934-vzsdvrwo	60	39	of	of	IN
cord-270934-vzsdvrwo	60	40	infection	infection	NN
cord-270934-vzsdvrwo	60	41	compared	compare	VBN
cord-270934-vzsdvrwo	60	42	to	to	IN
cord-270934-vzsdvrwo	60	43	ATRA	ATRA	NNP
cord-270934-vzsdvrwo	60	44	-	-	HYPH
cord-270934-vzsdvrwo	60	45	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	60	46	approaches	approach	NNS
cord-270934-vzsdvrwo	60	47	.	.	.
cord-270934-vzsdvrwo	61	1	[	[	-LRB-
cord-270934-vzsdvrwo	61	2	8	8	CD
cord-270934-vzsdvrwo	61	3	]	]	-RRB-
cord-270934-vzsdvrwo	61	4	High	high	JJ
cord-270934-vzsdvrwo	61	5	-	-	HYPH
cord-270934-vzsdvrwo	61	6	risk	risk	NN
cord-270934-vzsdvrwo	61	7	patients	patient	NNS
cord-270934-vzsdvrwo	61	8	must	must	MD
cord-270934-vzsdvrwo	61	9	still	still	RB
cord-270934-vzsdvrwo	61	10	receive	receive	VB
cord-270934-vzsdvrwo	61	11	a	a	DT
cord-270934-vzsdvrwo	61	12	regimen	regimen	NN
cord-270934-vzsdvrwo	61	13	that	that	WDT
cord-270934-vzsdvrwo	61	14	includes	include	VBZ
cord-270934-vzsdvrwo	61	15	a	a	DT
cord-270934-vzsdvrwo	61	16	cytotoxic	cytotoxic	JJ
cord-270934-vzsdvrwo	61	17	agent	agent	NN
cord-270934-vzsdvrwo	61	18	such	such	JJ
cord-270934-vzsdvrwo	61	19	as	as	IN
cord-270934-vzsdvrwo	61	20	an	an	DT
cord-270934-vzsdvrwo	61	21	anthracycline	anthracycline	JJ
cord-270934-vzsdvrwo	61	22	or	or	CC
cord-270934-vzsdvrwo	61	23	gemtuzumab	gemtuzumab	JJ
cord-270934-vzsdvrwo	61	24	ozogamcin	ozogamcin	NNS
cord-270934-vzsdvrwo	61	25	.	.	.
cord-270934-vzsdvrwo	62	1	QT	QT	NNP
cord-270934-vzsdvrwo	62	2	prolongation	prolongation	NN
cord-270934-vzsdvrwo	62	3	is	be	VBZ
cord-270934-vzsdvrwo	62	4	associated	associate	VBN
cord-270934-vzsdvrwo	62	5	with	with	IN
cord-270934-vzsdvrwo	62	6	several	several	JJ
cord-270934-vzsdvrwo	62	7	AML	AML	NNP
cord-270934-vzsdvrwo	62	8	therapies	therapy	NNS
cord-270934-vzsdvrwo	62	9	,	,	,
cord-270934-vzsdvrwo	62	10	including	include	VBG
cord-270934-vzsdvrwo	62	11	arsenic	arsenic	NN
cord-270934-vzsdvrwo	62	12	trioxide	trioxide	NN
cord-270934-vzsdvrwo	62	13	,	,	,
cord-270934-vzsdvrwo	62	14	gilteritinib	gilteritinib	NN
cord-270934-vzsdvrwo	62	15	,	,	,
cord-270934-vzsdvrwo	62	16	ivosidenib	ivosidenib	NN
cord-270934-vzsdvrwo	62	17	,	,	,
cord-270934-vzsdvrwo	62	18	and	and	CC
cord-270934-vzsdvrwo	62	19	enasidenib	enasidenib	NNP
cord-270934-vzsdvrwo	62	20	,	,	,
cord-270934-vzsdvrwo	62	21	particularly	particularly	RB
cord-270934-vzsdvrwo	62	22	if	if	IN
cord-270934-vzsdvrwo	62	23	given	give	VBN
cord-270934-vzsdvrwo	62	24	concomitantly	concomitantly	RB
cord-270934-vzsdvrwo	62	25	with	with	IN
cord-270934-vzsdvrwo	62	26	hydroxychloroquine	hydroxychloroquine	NNP
cord-270934-vzsdvrwo	62	27	,	,	,
cord-270934-vzsdvrwo	62	28	chloroquine	chloroquine	NN
cord-270934-vzsdvrwo	62	29	,	,	,
cord-270934-vzsdvrwo	62	30	and	and	CC
cord-270934-vzsdvrwo	62	31	azithromycin	azithromycin	NNP
cord-270934-vzsdvrwo	62	32	,	,	,
cord-270934-vzsdvrwo	62	33	which	which	WDT
cord-270934-vzsdvrwo	62	34	are	be	VBP
cord-270934-vzsdvrwo	62	35	commonly	commonly	RB
cord-270934-vzsdvrwo	62	36	used	use	VBN
cord-270934-vzsdvrwo	62	37	for	for	IN
cord-270934-vzsdvrwo	62	38	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	62	39	,	,	,
cord-270934-vzsdvrwo	62	40	and	and	CC
cord-270934-vzsdvrwo	62	41	other	other	JJ
cord-270934-vzsdvrwo	62	42	CYP3A4	CYP3A4	NNP
cord-270934-vzsdvrwo	62	43	inhibitors	inhibitor	NNS
cord-270934-vzsdvrwo	62	44	.	.	.
cord-270934-vzsdvrwo	63	1	Therefore	therefore	RB
cord-270934-vzsdvrwo	63	2	,	,	,
cord-270934-vzsdvrwo	63	3	serial	serial	JJ
cord-270934-vzsdvrwo	63	4	ECG	ECG	NNP
cord-270934-vzsdvrwo	63	5	monitoring	monitoring	NN
cord-270934-vzsdvrwo	63	6	is	be	VBZ
cord-270934-vzsdvrwo	63	7	essential	essential	JJ
cord-270934-vzsdvrwo	63	8	to	to	TO
cord-270934-vzsdvrwo	63	9	ensure	ensure	VB
cord-270934-vzsdvrwo	63	10	patient	patient	JJ
cord-270934-vzsdvrwo	63	11	safety	safety	NN
cord-270934-vzsdvrwo	63	12	.	.	.
cord-270934-vzsdvrwo	64	1	The	the	DT
cord-270934-vzsdvrwo	64	2	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	64	3	pandemic	pandemic	NN
cord-270934-vzsdvrwo	64	4	has	have	VBZ
cord-270934-vzsdvrwo	64	5	not	not	RB
cord-270934-vzsdvrwo	64	6	spared	spare	VBN
cord-270934-vzsdvrwo	64	7	stem	stem	NN
cord-270934-vzsdvrwo	64	8	cell	cell	NN
cord-270934-vzsdvrwo	64	9	transplant	transplant	NN
cord-270934-vzsdvrwo	64	10	,	,	,
cord-270934-vzsdvrwo	64	11	jeopardizing	jeopardize	VBG
cord-270934-vzsdvrwo	64	12	our	-PRON-	PRP$
cord-270934-vzsdvrwo	64	13	patients	patient	NNS
cord-270934-vzsdvrwo	64	14	'	'	POS
cord-270934-vzsdvrwo	64	15	chance	chance	NN
cord-270934-vzsdvrwo	64	16	to	to	TO
cord-270934-vzsdvrwo	64	17	receive	receive	VB
cord-270934-vzsdvrwo	64	18	potentially	potentially	RB
cord-270934-vzsdvrwo	64	19	curative	curative	JJ
cord-270934-vzsdvrwo	64	20	therapy	therapy	NN
cord-270934-vzsdvrwo	64	21	.	.	.
cord-270934-vzsdvrwo	65	1	The	the	DT
cord-270934-vzsdvrwo	65	2	stakes	stake	NNS
cord-270934-vzsdvrwo	65	3	are	be	VBP
cord-270934-vzsdvrwo	65	4	already	already	RB
cord-270934-vzsdvrwo	65	5	high	high	JJ
cord-270934-vzsdvrwo	65	6	for	for	IN
cord-270934-vzsdvrwo	65	7	stem	stem	NN
cord-270934-vzsdvrwo	65	8	cell	cell	NN
cord-270934-vzsdvrwo	65	9	transplant	transplant	NN
cord-270934-vzsdvrwo	65	10	patients	patient	NNS
cord-270934-vzsdvrwo	65	11	,	,	,
cord-270934-vzsdvrwo	65	12	who	who	WP
cord-270934-vzsdvrwo	65	13	endure	endure	VBP
cord-270934-vzsdvrwo	65	14	toxic	toxic	JJ
cord-270934-vzsdvrwo	65	15	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	65	16	and	and	CC
cord-270934-vzsdvrwo	65	17	a	a	DT
cord-270934-vzsdvrwo	65	18	weakened	weaken	VBN
cord-270934-vzsdvrwo	65	19	immune	immune	JJ
cord-270934-vzsdvrwo	65	20	system	system	NN
cord-270934-vzsdvrwo	65	21	suppressed	suppress	VBN
cord-270934-vzsdvrwo	65	22	for	for	IN
cord-270934-vzsdvrwo	65	23	months	month	NNS
cord-270934-vzsdvrwo	65	24	.	.	.
cord-270934-vzsdvrwo	66	1	The	the	DT
cord-270934-vzsdvrwo	66	2	vulnerability	vulnerability	NN
cord-270934-vzsdvrwo	66	3	to	to	IN
cord-270934-vzsdvrwo	66	4	infections	infection	NNS
cord-270934-vzsdvrwo	66	5	and	and	CC
cord-270934-vzsdvrwo	66	6	other	other	JJ
cord-270934-vzsdvrwo	66	7	complications	complication	NNS
cord-270934-vzsdvrwo	66	8	such	such	JJ
cord-270934-vzsdvrwo	66	9	as	as	IN
cord-270934-vzsdvrwo	66	10	graft	graft	NN
cord-270934-vzsdvrwo	66	11	-	-	HYPH
cord-270934-vzsdvrwo	66	12	versus	versus	IN
cord-270934-vzsdvrwo	66	13	-	-	HYPH
cord-270934-vzsdvrwo	66	14	host	host	NN
cord-270934-vzsdvrwo	66	15	disease	disease	NN
cord-270934-vzsdvrwo	66	16	can	can	MD
cord-270934-vzsdvrwo	66	17	be	be	VB
cord-270934-vzsdvrwo	66	18	successfully	successfully	RB
cord-270934-vzsdvrwo	66	19	managed	manage	VBN
cord-270934-vzsdvrwo	66	20	in	in	IN
cord-270934-vzsdvrwo	66	21	a	a	DT
cord-270934-vzsdvrwo	66	22	well	well	RB
cord-270934-vzsdvrwo	66	23	-	-	HYPH
cord-270934-vzsdvrwo	66	24	resourced	resource	VBN
cord-270934-vzsdvrwo	66	25	healthcare	healthcare	NN
cord-270934-vzsdvrwo	66	26	system	system	NN
cord-270934-vzsdvrwo	66	27	that	that	WDT
cord-270934-vzsdvrwo	66	28	we	-PRON-	PRP
cord-270934-vzsdvrwo	66	29	have	have	VBP
cord-270934-vzsdvrwo	66	30	taken	take	VBN
cord-270934-vzsdvrwo	66	31	for	for	IN
cord-270934-vzsdvrwo	66	32	granted	grant	VBN
cord-270934-vzsdvrwo	66	33	.	.	.
cord-270934-vzsdvrwo	67	1	As	as	IN
cord-270934-vzsdvrwo	67	2	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	67	3	pushes	push	VBZ
cord-270934-vzsdvrwo	67	4	hospitals	hospital	NNS
cord-270934-vzsdvrwo	67	5	to	to	IN
cord-270934-vzsdvrwo	67	6	their	-PRON-	PRP$
cord-270934-vzsdvrwo	67	7	limits	limit	NNS
cord-270934-vzsdvrwo	67	8	and	and	CC
cord-270934-vzsdvrwo	67	9	beyond	beyond	RB
cord-270934-vzsdvrwo	67	10	,	,	,
cord-270934-vzsdvrwo	67	11	we	-PRON-	PRP
cord-270934-vzsdvrwo	67	12	are	be	VBP
cord-270934-vzsdvrwo	67	13	now	now	RB
cord-270934-vzsdvrwo	67	14	forced	force	VBN
cord-270934-vzsdvrwo	67	15	to	to	TO
cord-270934-vzsdvrwo	67	16	consider	consider	VB
cord-270934-vzsdvrwo	67	17	the	the	DT
cord-270934-vzsdvrwo	67	18	possibility	possibility	NN
cord-270934-vzsdvrwo	67	19	that	that	IN
cord-270934-vzsdvrwo	67	20	our	-PRON-	PRP$
cord-270934-vzsdvrwo	67	21	patients	patient	NNS
cord-270934-vzsdvrwo	67	22	may	may	MD
cord-270934-vzsdvrwo	67	23	not	not	RB
cord-270934-vzsdvrwo	67	24	have	have	VB
cord-270934-vzsdvrwo	67	25	a	a	DT
cord-270934-vzsdvrwo	67	26	ventilator	ventilator	NN
cord-270934-vzsdvrwo	67	27	or	or	CC
cord-270934-vzsdvrwo	67	28	an	an	DT
cord-270934-vzsdvrwo	67	29	ICU	ICU	NNP
cord-270934-vzsdvrwo	67	30	bed	bed	NN
cord-270934-vzsdvrwo	67	31	available	available	JJ
cord-270934-vzsdvrwo	67	32	to	to	IN
cord-270934-vzsdvrwo	67	33	them	-PRON-	PRP
cord-270934-vzsdvrwo	68	1	should	should	MD
cord-270934-vzsdvrwo	68	2	they	-PRON-	PRP
cord-270934-vzsdvrwo	68	3	need	need	VB
cord-270934-vzsdvrwo	68	4	one	one	CD
cord-270934-vzsdvrwo	68	5	.	.	.
cord-270934-vzsdvrwo	69	1	Patients	patient	NNS
cord-270934-vzsdvrwo	69	2	undergoing	undergo	VBG
cord-270934-vzsdvrwo	69	3	allogeneic	allogeneic	IN
cord-270934-vzsdvrwo	69	4	transplantation	transplantation	NN
cord-270934-vzsdvrwo	69	5	usually	usually	RB
cord-270934-vzsdvrwo	69	6	spend	spend	VBP
cord-270934-vzsdvrwo	69	7	up	up	IN
cord-270934-vzsdvrwo	69	8	to	to	TO
cord-270934-vzsdvrwo	69	9	five	five	CD
cord-270934-vzsdvrwo	69	10	weeks	week	NNS
cord-270934-vzsdvrwo	69	11	in	in	IN
cord-270934-vzsdvrwo	69	12	the	the	DT
cord-270934-vzsdvrwo	69	13	hospital	hospital	NN
cord-270934-vzsdvrwo	69	14	,	,	,
cord-270934-vzsdvrwo	69	15	and	and	CC
cord-270934-vzsdvrwo	69	16	now	now	RB
cord-270934-vzsdvrwo	69	17	they	-PRON-	PRP
cord-270934-vzsdvrwo	69	18	spend	spend	VBP
cord-270934-vzsdvrwo	69	19	that	that	DT
cord-270934-vzsdvrwo	69	20	time	time	NN
cord-270934-vzsdvrwo	69	21	alone	alone	RB
cord-270934-vzsdvrwo	69	22	as	as	IN
cord-270934-vzsdvrwo	69	23	hospitals	hospital	NNS
cord-270934-vzsdvrwo	69	24	have	have	VBP
cord-270934-vzsdvrwo	69	25	moved	move	VBN
cord-270934-vzsdvrwo	69	26	to	to	IN
cord-270934-vzsdvrwo	69	27	no	no	DT
cord-270934-vzsdvrwo	69	28	-	-	HYPH
cord-270934-vzsdvrwo	69	29	visitor	visitor	NN
cord-270934-vzsdvrwo	69	30	policies	policy	NNS
cord-270934-vzsdvrwo	69	31	to	to	TO
cord-270934-vzsdvrwo	69	32	prevent	prevent	VB
cord-270934-vzsdvrwo	69	33	the	the	DT
cord-270934-vzsdvrwo	69	34	spread	spread	NN
cord-270934-vzsdvrwo	69	35	of	of	IN
cord-270934-vzsdvrwo	69	36	COVID-19	covid-19	NN
cord-270934-vzsdvrwo	69	37	to	to	IN
cord-270934-vzsdvrwo	69	38	hospitalized	hospitalize	VBN
cord-270934-vzsdvrwo	69	39	patients	patient	NNS
cord-270934-vzsdvrwo	69	40	.	.	.
cord-270934-vzsdvrwo	70	1	Travel	travel	NN
cord-270934-vzsdvrwo	70	2	restrictions	restriction	NNS
cord-270934-vzsdvrwo	70	3	also	also	RB
cord-270934-vzsdvrwo	70	4	impacted	impact	VBD
cord-270934-vzsdvrwo	70	5	stem	stem	NN
cord-270934-vzsdvrwo	70	6	cell	cell	NN
cord-270934-vzsdvrwo	70	7	transplants	transplant	NNS
cord-270934-vzsdvrwo	70	8	.	.	.
cord-270934-vzsdvrwo	71	1	Often	often	RB
cord-270934-vzsdvrwo	71	2	called	call	VBN
cord-270934-vzsdvrwo	71	3	"	"	``
cord-270934-vzsdvrwo	71	4	the	the	DT
cord-270934-vzsdvrwo	71	5	gift	gift	NN
cord-270934-vzsdvrwo	71	6	of	of	IN
cord-270934-vzsdvrwo	71	7	life	life	NN
cord-270934-vzsdvrwo	71	8	,	,	,
cord-270934-vzsdvrwo	71	9	"	"	''
cord-270934-vzsdvrwo	71	10	bone	bone	NN
cord-270934-vzsdvrwo	71	11	marrow	marrow	NN
cord-270934-vzsdvrwo	71	12	stem	stem	NN
cord-270934-vzsdvrwo	71	13	cells	cell	NNS
cord-270934-vzsdvrwo	71	14	donors	donor	NNS
cord-270934-vzsdvrwo	71	15	hail	hail	VBP
cord-270934-vzsdvrwo	71	16	from	from	IN
cord-270934-vzsdvrwo	71	17	all	all	DT
cord-270934-vzsdvrwo	71	18	countries	country	NNS
cord-270934-vzsdvrwo	71	19	and	and	CC
cord-270934-vzsdvrwo	71	20	ethnicities	ethnicity	NNS
cord-270934-vzsdvrwo	71	21	.	.	.
cord-270934-vzsdvrwo	72	1	Unencumbered	unencumbered	JJ
cord-270934-vzsdvrwo	72	2	by	by	IN
cord-270934-vzsdvrwo	72	3	political	political	JJ
cord-270934-vzsdvrwo	72	4	and	and	CC
cord-270934-vzsdvrwo	72	5	geographical	geographical	JJ
cord-270934-vzsdvrwo	72	6	boundaries	boundary	NNS
cord-270934-vzsdvrwo	72	7	,	,	,
cord-270934-vzsdvrwo	72	8	a	a	DT
cord-270934-vzsdvrwo	72	9	patient	patient	NN
cord-270934-vzsdvrwo	72	10	can	can	MD
cord-270934-vzsdvrwo	72	11	receive	receive	VB
cord-270934-vzsdvrwo	72	12	stem	stem	NN
cord-270934-vzsdvrwo	72	13	cells	cell	NNS
cord-270934-vzsdvrwo	72	14	from	from	IN
cord-270934-vzsdvrwo	72	15	many	many	JJ
cord-270934-vzsdvrwo	72	16	countries	country	NNS
cord-270934-vzsdvrwo	72	17	across	across	IN
cord-270934-vzsdvrwo	72	18	the	the	DT
cord-270934-vzsdvrwo	72	19	globe	globe	NN
cord-270934-vzsdvrwo	72	20	.	.	.
cord-270934-vzsdvrwo	73	1	In	in	IN
cord-270934-vzsdvrwo	73	2	these	these	DT
cord-270934-vzsdvrwo	73	3	times	time	NNS
cord-270934-vzsdvrwo	73	4	of	of	IN
cord-270934-vzsdvrwo	73	5	uncertainty	uncertainty	NN
cord-270934-vzsdvrwo	73	6	,	,	,
cord-270934-vzsdvrwo	73	7	we	-PRON-	PRP
cord-270934-vzsdvrwo	73	8	fear	fear	VBP
cord-270934-vzsdvrwo	73	9	that	that	IN
cord-270934-vzsdvrwo	73	10	a	a	DT
cord-270934-vzsdvrwo	73	11	patient	patient	NN
cord-270934-vzsdvrwo	73	12	being	be	VBG
cord-270934-vzsdvrwo	73	13	prepped	preppe	VBN
cord-270934-vzsdvrwo	73	14	for	for	IN
cord-270934-vzsdvrwo	73	15	transplant	transplant	NN
cord-270934-vzsdvrwo	73	16	is	be	VBZ
cord-270934-vzsdvrwo	73	17	unable	unable	JJ
cord-270934-vzsdvrwo	73	18	to	to	TO
cord-270934-vzsdvrwo	73	19	receive	receive	VB
cord-270934-vzsdvrwo	73	20	their	-PRON-	PRP$
cord-270934-vzsdvrwo	73	21	stem	stem	NN
cord-270934-vzsdvrwo	73	22	cells	cell	NNS
cord-270934-vzsdvrwo	73	23	.	.	.
cord-270934-vzsdvrwo	74	1	The	the	DT
cord-270934-vzsdvrwo	74	2	American	American	NNP
cord-270934-vzsdvrwo	74	3	Society	Society	NNP
cord-270934-vzsdvrwo	74	4	of	of	IN
cord-270934-vzsdvrwo	74	5	Transplantation	Transplantation	NNP
cord-270934-vzsdvrwo	74	6	and	and	CC
cord-270934-vzsdvrwo	74	7	Cellular	Cellular	NNP
cord-270934-vzsdvrwo	74	8	Therapy	Therapy	NNP
cord-270934-vzsdvrwo	74	9	set	set	VBD
cord-270934-vzsdvrwo	74	10	forth	forth	RP
cord-270934-vzsdvrwo	74	11	guidelines	guideline	NNS
cord-270934-vzsdvrwo	74	12	about	about	IN
cord-270934-vzsdvrwo	74	13	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	74	14	.	.	.
cord-270934-vzsdvrwo	75	1	[	[	-LRB-
cord-270934-vzsdvrwo	75	2	9	9	LS
cord-270934-vzsdvrwo	75	3	]	]	-RRB-
cord-270934-vzsdvrwo	75	4	We	-PRON-	PRP
cord-270934-vzsdvrwo	75	5	currently	currently	RB
cord-270934-vzsdvrwo	75	6	do	do	VBP
cord-270934-vzsdvrwo	75	7	not	not	RB
cord-270934-vzsdvrwo	75	8	know	know	VB
cord-270934-vzsdvrwo	75	9	whether	whether	IN
cord-270934-vzsdvrwo	75	10	this	this	DT
cord-270934-vzsdvrwo	75	11	virus	virus	NN
cord-270934-vzsdvrwo	75	12	can	can	MD
cord-270934-vzsdvrwo	75	13	be	be	VB
cord-270934-vzsdvrwo	75	14	transmitted	transmit	VBN
cord-270934-vzsdvrwo	75	15	in	in	IN
cord-270934-vzsdvrwo	75	16	the	the	DT
cord-270934-vzsdvrwo	75	17	blood	blood	NN
cord-270934-vzsdvrwo	75	18	.	.	.
cord-270934-vzsdvrwo	76	1	Given	give	VBN
cord-270934-vzsdvrwo	76	2	the	the	DT
cord-270934-vzsdvrwo	76	3	weakened	weakened	JJ
cord-270934-vzsdvrwo	76	4	immune	immune	JJ
cord-270934-vzsdvrwo	76	5	systems	system	NNS
cord-270934-vzsdvrwo	76	6	our	-PRON-	PRP$
cord-270934-vzsdvrwo	76	7	patients	patient	NNS
cord-270934-vzsdvrwo	76	8	have	have	VBP
cord-270934-vzsdvrwo	76	9	and	and	CC
cord-270934-vzsdvrwo	76	10	the	the	DT
cord-270934-vzsdvrwo	76	11	toxic	toxic	JJ
cord-270934-vzsdvrwo	76	12	treatments	treatment	NNS
cord-270934-vzsdvrwo	76	13	they	-PRON-	PRP
cord-270934-vzsdvrwo	76	14	need	need	VBP
cord-270934-vzsdvrwo	76	15	,	,	,
cord-270934-vzsdvrwo	76	16	we	-PRON-	PRP
cord-270934-vzsdvrwo	76	17	must	must	MD
cord-270934-vzsdvrwo	76	18	protect	protect	VB
cord-270934-vzsdvrwo	76	19	them	-PRON-	PRP
cord-270934-vzsdvrwo	76	20	at	at	IN
cord-270934-vzsdvrwo	76	21	all	all	DT
cord-270934-vzsdvrwo	76	22	costs	cost	NNS
cord-270934-vzsdvrwo	76	23	.	.	.
cord-270934-vzsdvrwo	77	1	Testing	test	VBG
cord-270934-vzsdvrwo	77	2	donors	donor	NNS
cord-270934-vzsdvrwo	77	3	for	for	IN
cord-270934-vzsdvrwo	77	4	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	77	5	,	,	,
cord-270934-vzsdvrwo	77	6	cryopreserving	cryopreserve	VBG
cord-270934-vzsdvrwo	77	7	their	-PRON-	PRP$
cord-270934-vzsdvrwo	77	8	cells	cell	NNS
cord-270934-vzsdvrwo	77	9	ahead	ahead	RB
cord-270934-vzsdvrwo	77	10	of	of	IN
cord-270934-vzsdvrwo	77	11	time	time	NN
cord-270934-vzsdvrwo	77	12	,	,	,
cord-270934-vzsdvrwo	77	13	ensuring	ensure	VBG
cord-270934-vzsdvrwo	77	14	both	both	DT
cord-270934-vzsdvrwo	77	15	patients	patient	NNS
cord-270934-vzsdvrwo	77	16	and	and	CC
cord-270934-vzsdvrwo	77	17	donors	donor	NNS
cord-270934-vzsdvrwo	77	18	avoid	avoid	VBP
cord-270934-vzsdvrwo	77	19	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	77	20	exposure	exposure	NN
cord-270934-vzsdvrwo	77	21	,	,	,
cord-270934-vzsdvrwo	77	22	and	and	CC
cord-270934-vzsdvrwo	77	23	testing	test	VBG
cord-270934-vzsdvrwo	77	24	patients	patient	NNS
cord-270934-vzsdvrwo	77	25	before	before	IN
cord-270934-vzsdvrwo	77	26	the	the	DT
cord-270934-vzsdvrwo	77	27	start	start	NN
cord-270934-vzsdvrwo	77	28	of	of	IN
cord-270934-vzsdvrwo	77	29	conditioning	conditioning	NN
cord-270934-vzsdvrwo	77	30	are	be	VBP
cord-270934-vzsdvrwo	77	31	recommended	recommend	VBN
cord-270934-vzsdvrwo	77	32	.	.	.
cord-270934-vzsdvrwo	78	1	Finding	find	VBG
cord-270934-vzsdvrwo	78	2	a	a	DT
cord-270934-vzsdvrwo	78	3	match	match	NN
cord-270934-vzsdvrwo	78	4	for	for	IN
cord-270934-vzsdvrwo	78	5	stem	stem	NN
cord-270934-vzsdvrwo	78	6	cell	cell	NN
cord-270934-vzsdvrwo	78	7	transplant	transplant	NN
cord-270934-vzsdvrwo	78	8	is	be	VBZ
cord-270934-vzsdvrwo	78	9	hard	hard	JJ
cord-270934-vzsdvrwo	78	10	enough	enough	RB
cord-270934-vzsdvrwo	78	11	;	;	:
cord-270934-vzsdvrwo	78	12	having	have	VBG
cord-270934-vzsdvrwo	78	13	to	to	TO
cord-270934-vzsdvrwo	78	14	exclude	exclude	VB
cord-270934-vzsdvrwo	78	15	a	a	DT
cord-270934-vzsdvrwo	78	16	good	good	JJ
cord-270934-vzsdvrwo	78	17	match	match	NN
cord-270934-vzsdvrwo	78	18	or	or	CC
cord-270934-vzsdvrwo	78	19	delay	delay	NN
cord-270934-vzsdvrwo	78	20	transplant	transplant	NN
cord-270934-vzsdvrwo	78	21	further	further	RB
cord-270934-vzsdvrwo	78	22	complicates	complicate	VBZ
cord-270934-vzsdvrwo	78	23	our	-PRON-	PRP$
cord-270934-vzsdvrwo	78	24	ability	ability	NN
cord-270934-vzsdvrwo	78	25	to	to	TO
cord-270934-vzsdvrwo	78	26	deliver	deliver	VB
cord-270934-vzsdvrwo	78	27	care	care	NN
cord-270934-vzsdvrwo	78	28	.	.	.
cord-270934-vzsdvrwo	79	1	If	if	IN
cord-270934-vzsdvrwo	79	2	translational	translational	JJ
cord-270934-vzsdvrwo	79	3	research	research	NN
cord-270934-vzsdvrwo	79	4	is	be	VBZ
cord-270934-vzsdvrwo	79	5	the	the	DT
cord-270934-vzsdvrwo	79	6	bridge	bridge	NN
cord-270934-vzsdvrwo	79	7	between	between	IN
cord-270934-vzsdvrwo	79	8	basic	basic	JJ
cord-270934-vzsdvrwo	79	9	science	science	NN
cord-270934-vzsdvrwo	79	10	and	and	CC
cord-270934-vzsdvrwo	79	11	clinical	clinical	JJ
cord-270934-vzsdvrwo	79	12	practice	practice	NN
cord-270934-vzsdvrwo	79	13	,	,	,
cord-270934-vzsdvrwo	79	14	biobanks	biobank	NNS
cord-270934-vzsdvrwo	79	15	are	be	VBP
cord-270934-vzsdvrwo	79	16	its	-PRON-	PRP$
cord-270934-vzsdvrwo	79	17	foundation	foundation	NN
cord-270934-vzsdvrwo	79	18	.	.	.
cord-270934-vzsdvrwo	80	1	Our	-PRON-	PRP$
cord-270934-vzsdvrwo	80	2	Tissue	tissue	NN
cord-270934-vzsdvrwo	80	3	Repository	repository	NN
cord-270934-vzsdvrwo	80	4	has	have	VBZ
cord-270934-vzsdvrwo	80	5	been	be	VBN
cord-270934-vzsdvrwo	80	6	collecting	collect	VBG
cord-270934-vzsdvrwo	80	7	specimens	specimen	NNS
cord-270934-vzsdvrwo	80	8	,	,	,
cord-270934-vzsdvrwo	80	9	including	include	VBG
cord-270934-vzsdvrwo	80	10	blood	blood	NN
cord-270934-vzsdvrwo	80	11	and	and	CC
cord-270934-vzsdvrwo	80	12	bone	bone	NN
cord-270934-vzsdvrwo	80	13	marrows	marrow	NNS
cord-270934-vzsdvrwo	80	14	from	from	IN
cord-270934-vzsdvrwo	80	15	patients	patient	NNS
cord-270934-vzsdvrwo	80	16	for	for	IN
cord-270934-vzsdvrwo	80	17	the	the	DT
cord-270934-vzsdvrwo	80	18	last	last	JJ
cord-270934-vzsdvrwo	80	19	35	35	CD
cord-270934-vzsdvrwo	80	20	+	+	SYM
cord-270934-vzsdvrwo	80	21	years	year	NNS
cord-270934-vzsdvrwo	80	22	,	,	,
cord-270934-vzsdvrwo	80	23	representing	represent	VBG
cord-270934-vzsdvrwo	80	24	one	one	CD
cord-270934-vzsdvrwo	80	25	of	of	IN
cord-270934-vzsdvrwo	80	26	the	the	DT
cord-270934-vzsdvrwo	80	27	largest	large	JJS
cord-270934-vzsdvrwo	80	28	biobanks	biobank	NNS
cord-270934-vzsdvrwo	80	29	in	in	IN
cord-270934-vzsdvrwo	80	30	the	the	DT
cord-270934-vzsdvrwo	80	31	world	world	NN
cord-270934-vzsdvrwo	80	32	with	with	IN
cord-270934-vzsdvrwo	80	33	wellannotated	wellannotated	JJ
cord-270934-vzsdvrwo	80	34	tissue	tissue	NN
cord-270934-vzsdvrwo	80	35	samples	sample	NNS
cord-270934-vzsdvrwo	80	36	.	.	.
cord-270934-vzsdvrwo	81	1	The	the	DT
cord-270934-vzsdvrwo	81	2	post	post	JJ
cord-270934-vzsdvrwo	81	3	-	-	JJ
cord-270934-vzsdvrwo	81	4	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	81	5	shift	shift	NN
cord-270934-vzsdvrwo	81	6	to	to	IN
cord-270934-vzsdvrwo	81	7	telemedicine	telemedicine	NN
cord-270934-vzsdvrwo	81	8	means	mean	VBZ
cord-270934-vzsdvrwo	81	9	no	no	DT
cord-270934-vzsdvrwo	81	10	patients	patient	NNS
cord-270934-vzsdvrwo	81	11	in	in	IN
cord-270934-vzsdvrwo	81	12	clinics	clinic	NNS
cord-270934-vzsdvrwo	81	13	and	and	CC
cord-270934-vzsdvrwo	81	14	no	no	DT
cord-270934-vzsdvrwo	81	15	access	access	NN
cord-270934-vzsdvrwo	81	16	to	to	IN
cord-270934-vzsdvrwo	81	17	fresh	fresh	JJ
cord-270934-vzsdvrwo	81	18	samples	sample	NNS
cord-270934-vzsdvrwo	81	19	.	.	.
cord-270934-vzsdvrwo	82	1	Consequences	consequence	NNS
cord-270934-vzsdvrwo	82	2	for	for	IN
cord-270934-vzsdvrwo	82	3	the	the	DT
cord-270934-vzsdvrwo	82	4	lab	lab	NN
cord-270934-vzsdvrwo	82	5	include	include	VBP
cord-270934-vzsdvrwo	82	6	loss	loss	NN
cord-270934-vzsdvrwo	82	7	of	of	IN
cord-270934-vzsdvrwo	82	8	valuable	valuable	JJ
cord-270934-vzsdvrwo	82	9	ongoing	ongoing	JJ
cord-270934-vzsdvrwo	82	10	cultures	culture	NNS
cord-270934-vzsdvrwo	82	11	for	for	IN
cord-270934-vzsdvrwo	82	12	lack	lack	NN
cord-270934-vzsdvrwo	82	13	of	of	IN
cord-270934-vzsdvrwo	82	14	fresh	fresh	JJ
cord-270934-vzsdvrwo	82	15	cells	cell	NNS
cord-270934-vzsdvrwo	82	16	and	and	CC
cord-270934-vzsdvrwo	82	17	nutrients	nutrient	NNS
cord-270934-vzsdvrwo	82	18	,	,	,
cord-270934-vzsdvrwo	82	19	expiration	expiration	NN
cord-270934-vzsdvrwo	82	20	of	of	IN
cord-270934-vzsdvrwo	82	21	precious	precious	JJ
cord-270934-vzsdvrwo	82	22	reagents	reagent	NNS
cord-270934-vzsdvrwo	82	23	,	,	,
cord-270934-vzsdvrwo	82	24	and	and	CC
cord-270934-vzsdvrwo	82	25	wasted	waste	VBN
cord-270934-vzsdvrwo	82	26	experiments	experiment	NNS
cord-270934-vzsdvrwo	82	27	.	.	.
cord-270934-vzsdvrwo	83	1	With	with	IN
cord-270934-vzsdvrwo	83	2	the	the	DT
cord-270934-vzsdvrwo	83	3	implementation	implementation	NN
cord-270934-vzsdvrwo	83	4	of	of	IN
cord-270934-vzsdvrwo	83	5	social	social	JJ
cord-270934-vzsdvrwo	83	6	distancing	distancing	NN
cord-270934-vzsdvrwo	83	7	by	by	IN
cord-270934-vzsdvrwo	83	8	federal	federal	JJ
cord-270934-vzsdvrwo	83	9	and	and	CC
cord-270934-vzsdvrwo	83	10	state	state	NN
cord-270934-vzsdvrwo	83	11	governments	government	NNS
cord-270934-vzsdvrwo	83	12	,	,	,
cord-270934-vzsdvrwo	83	13	the	the	DT
cord-270934-vzsdvrwo	83	14	University	University	NNP
cord-270934-vzsdvrwo	83	15	suspended	suspend	VBD
cord-270934-vzsdvrwo	83	16	nonessential	nonessential	JJ
cord-270934-vzsdvrwo	83	17	lab	lab	NN
cord-270934-vzsdvrwo	83	18	research	research	NN
cord-270934-vzsdvrwo	83	19	.	.	.
cord-270934-vzsdvrwo	84	1	Therefore	therefore	RB
cord-270934-vzsdvrwo	84	2	,	,	,
cord-270934-vzsdvrwo	84	3	freezing	freeze	VBG
cord-270934-vzsdvrwo	84	4	,	,	,
cord-270934-vzsdvrwo	84	5	thawing	thawing	NN
cord-270934-vzsdvrwo	84	6	,	,	,
cord-270934-vzsdvrwo	84	7	and	and	CC
cord-270934-vzsdvrwo	84	8	expanding	expand	VBG
cord-270934-vzsdvrwo	84	9	cells	cell	NNS
cord-270934-vzsdvrwo	84	10	after	after	IN
cord-270934-vzsdvrwo	84	11	this	this	DT
cord-270934-vzsdvrwo	84	12	pause	pause	NN
cord-270934-vzsdvrwo	84	13	in	in	IN
cord-270934-vzsdvrwo	84	14	research	research	NN
cord-270934-vzsdvrwo	84	15	will	will	MD
cord-270934-vzsdvrwo	84	16	require	require	VB
cord-270934-vzsdvrwo	84	17	a	a	DT
cord-270934-vzsdvrwo	84	18	significant	significant	JJ
cord-270934-vzsdvrwo	84	19	investment	investment	NN
cord-270934-vzsdvrwo	84	20	of	of	IN
cord-270934-vzsdvrwo	84	21	time	time	NN
cord-270934-vzsdvrwo	84	22	and	and	CC
cord-270934-vzsdvrwo	84	23	resources	resource	NNS
cord-270934-vzsdvrwo	84	24	.	.	.
cord-270934-vzsdvrwo	85	1	This	this	DT
cord-270934-vzsdvrwo	85	2	unexpected	unexpected	JJ
cord-270934-vzsdvrwo	85	3	break	break	NN
cord-270934-vzsdvrwo	85	4	in	in	IN
cord-270934-vzsdvrwo	85	5	bench	bench	NN
cord-270934-vzsdvrwo	85	6	research	research	NN
cord-270934-vzsdvrwo	85	7	allows	allow	VBZ
cord-270934-vzsdvrwo	85	8	more	more	JJR
cord-270934-vzsdvrwo	85	9	time	time	NN
cord-270934-vzsdvrwo	85	10	for	for	IN
cord-270934-vzsdvrwo	85	11	updating	update	VBG
cord-270934-vzsdvrwo	85	12	pathology	pathology	NN
cord-270934-vzsdvrwo	85	13	and	and	CC
cord-270934-vzsdvrwo	85	14	clinical	clinical	JJ
cord-270934-vzsdvrwo	85	15	information	information	NN
cord-270934-vzsdvrwo	85	16	in	in	IN
cord-270934-vzsdvrwo	85	17	the	the	DT
cord-270934-vzsdvrwo	85	18	databank	databank	NN
cord-270934-vzsdvrwo	85	19	,	,	,
cord-270934-vzsdvrwo	85	20	analyzing	analyze	VBG
cord-270934-vzsdvrwo	85	21	data	datum	NNS
cord-270934-vzsdvrwo	85	22	,	,	,
cord-270934-vzsdvrwo	85	23	finalizing	finalize	VBG
cord-270934-vzsdvrwo	85	24	manuscripts	manuscript	NNS
cord-270934-vzsdvrwo	85	25	,	,	,
cord-270934-vzsdvrwo	85	26	reviewing	review	VBG
cord-270934-vzsdvrwo	85	27	experiments	experiment	NNS
cord-270934-vzsdvrwo	85	28	,	,	,
cord-270934-vzsdvrwo	85	29	completing	complete	VBG
cord-270934-vzsdvrwo	85	30	lab	lab	NN
cord-270934-vzsdvrwo	85	31	-	-	HYPH
cord-270934-vzsdvrwo	85	32	books	book	NNS
cord-270934-vzsdvrwo	85	33	,	,	,
cord-270934-vzsdvrwo	85	34	and	and	CC
cord-270934-vzsdvrwo	85	35	yes	yes	UH
cord-270934-vzsdvrwo	85	36	,	,	,
cord-270934-vzsdvrwo	85	37	writing	write	VBG
cord-270934-vzsdvrwo	85	38	all	all	PDT
cord-270934-vzsdvrwo	85	39	those	those	DT
cord-270934-vzsdvrwo	85	40	overdue	overdue	JJ
cord-270934-vzsdvrwo	85	41	recommendation	recommendation	NN
cord-270934-vzsdvrwo	85	42	letters	letter	NNS
cord-270934-vzsdvrwo	85	43	.	.	.
cord-270934-vzsdvrwo	86	1	Lab	lab	NN
cord-270934-vzsdvrwo	86	2	meetings	meeting	NNS
cord-270934-vzsdvrwo	86	3	and	and	CC
cord-270934-vzsdvrwo	86	4	discussions	discussion	NNS
cord-270934-vzsdvrwo	86	5	regarding	regard	VBG
cord-270934-vzsdvrwo	86	6	grants	grant	NNS
cord-270934-vzsdvrwo	86	7	and	and	CC
cord-270934-vzsdvrwo	86	8	future	future	JJ
cord-270934-vzsdvrwo	86	9	prioritization	prioritization	NN
cord-270934-vzsdvrwo	86	10	of	of	IN
cord-270934-vzsdvrwo	86	11	projects	project	NNS
cord-270934-vzsdvrwo	86	12	are	be	VBP
cord-270934-vzsdvrwo	86	13	taking	take	VBG
cord-270934-vzsdvrwo	86	14	place	place	NN
cord-270934-vzsdvrwo	86	15	through	through	IN
cord-270934-vzsdvrwo	86	16	teleconferencing	teleconferencing	NN
cord-270934-vzsdvrwo	86	17	,	,	,
cord-270934-vzsdvrwo	86	18	with	with	IN
cord-270934-vzsdvrwo	86	19	designated	designate	VBN
cord-270934-vzsdvrwo	86	20	emergency	emergency	NN
cord-270934-vzsdvrwo	86	21	personnel	personnel	NNS
cord-270934-vzsdvrwo	86	22	making	make	VBG
cord-270934-vzsdvrwo	86	23	the	the	DT
cord-270934-vzsdvrwo	86	24	trip	trip	NN
cord-270934-vzsdvrwo	86	25	physically	physically	RB
cord-270934-vzsdvrwo	86	26	once	once	RB
cord-270934-vzsdvrwo	86	27	a	a	DT
cord-270934-vzsdvrwo	86	28	week	week	NN
cord-270934-vzsdvrwo	86	29	to	to	TO
cord-270934-vzsdvrwo	86	30	ensure	ensure	VB
cord-270934-vzsdvrwo	86	31	that	that	IN
cord-270934-vzsdvrwo	86	32	no	no	DT
cord-270934-vzsdvrwo	86	33	chemicals	chemical	NNS
cord-270934-vzsdvrwo	86	34	are	be	VBP
cord-270934-vzsdvrwo	86	35	leaking	leak	VBG
cord-270934-vzsdvrwo	86	36	,	,	,
cord-270934-vzsdvrwo	86	37	freezers	freezer	NNS
cord-270934-vzsdvrwo	86	38	housing	housing	VBP
cord-270934-vzsdvrwo	86	39	the	the	DT
cord-270934-vzsdvrwo	86	40	priceless	priceless	JJ
cord-270934-vzsdvrwo	86	41	tissue	tissue	NN
cord-270934-vzsdvrwo	86	42	samples	sample	NNS
cord-270934-vzsdvrwo	86	43	are	be	VBP
cord-270934-vzsdvrwo	86	44	working	work	VBG
cord-270934-vzsdvrwo	86	45	,	,	,
cord-270934-vzsdvrwo	86	46	and	and	CC
cord-270934-vzsdvrwo	86	47	equipment	equipment	NN
cord-270934-vzsdvrwo	86	48	is	be	VBZ
cord-270934-vzsdvrwo	86	49	safe	safe	JJ
cord-270934-vzsdvrwo	86	50	.	.	.
cord-270934-vzsdvrwo	87	1	In	in	IN
cord-270934-vzsdvrwo	87	2	summary	summary	NN
cord-270934-vzsdvrwo	87	3	,	,	,
cord-270934-vzsdvrwo	87	4	COVID-19	COVID-19	NNP
cord-270934-vzsdvrwo	87	5	has	have	VBZ
cord-270934-vzsdvrwo	87	6	fundamentally	fundamentally	RB
cord-270934-vzsdvrwo	87	7	transformed	transform	VBN
cord-270934-vzsdvrwo	87	8	how	how	WRB
cord-270934-vzsdvrwo	87	9	we	-PRON-	PRP
cord-270934-vzsdvrwo	87	10	care	care	VBP
cord-270934-vzsdvrwo	87	11	for	for	IN
cord-270934-vzsdvrwo	87	12	our	-PRON-	PRP$
cord-270934-vzsdvrwo	87	13	MDS	MDS	NNP
cord-270934-vzsdvrwo	87	14	and	and	CC
cord-270934-vzsdvrwo	87	15	AML	AML	NNP
cord-270934-vzsdvrwo	87	16	patients	patient	NNS
cord-270934-vzsdvrwo	87	17	,	,	,
cord-270934-vzsdvrwo	87	18	social	social	JJ
cord-270934-vzsdvrwo	87	19	isolation	isolation	NN
cord-270934-vzsdvrwo	87	20	forcing	force	VBG
cord-270934-vzsdvrwo	87	21	the	the	DT
cord-270934-vzsdvrwo	87	22	practice	practice	NN
cord-270934-vzsdvrwo	87	23	of	of	IN
cord-270934-vzsdvrwo	87	24	remotely	remotely	RB
cord-270934-vzsdvrwo	87	25	delivered	deliver	VBN
cord-270934-vzsdvrwo	87	26	healthcare	healthcare	NN
cord-270934-vzsdvrwo	87	27	whenever	whenever	WRB
cord-270934-vzsdvrwo	87	28	possible	possible	JJ
cord-270934-vzsdvrwo	87	29	.	.	.
cord-270934-vzsdvrwo	88	1	If	if	IN
cord-270934-vzsdvrwo	88	2	the	the	DT
cord-270934-vzsdvrwo	88	3	best	good	JJS
cord-270934-vzsdvrwo	88	4	cure	cure	NN
cord-270934-vzsdvrwo	88	5	for	for	IN
cord-270934-vzsdvrwo	88	6	this	this	DT
cord-270934-vzsdvrwo	88	7	deadly	deadly	JJ
cord-270934-vzsdvrwo	88	8	virus	virus	NN
cord-270934-vzsdvrwo	88	9	is	be	VBZ
cord-270934-vzsdvrwo	88	10	to	to	TO
cord-270934-vzsdvrwo	88	11	avoid	avoid	VB
cord-270934-vzsdvrwo	88	12	it	-PRON-	PRP
cord-270934-vzsdvrwo	88	13	altogether	altogether	RB
cord-270934-vzsdvrwo	88	14	,	,	,
cord-270934-vzsdvrwo	88	15	the	the	DT
cord-270934-vzsdvrwo	88	16	same	same	JJ
cord-270934-vzsdvrwo	88	17	principle	principle	NN
cord-270934-vzsdvrwo	88	18	should	should	MD
cord-270934-vzsdvrwo	88	19	be	be	VB
cord-270934-vzsdvrwo	88	20	applied	apply	VBN
cord-270934-vzsdvrwo	88	21	to	to	IN
cord-270934-vzsdvrwo	88	22	cancer	cancer	NN
cord-270934-vzsdvrwo	88	23	with	with	IN
cord-270934-vzsdvrwo	88	24	greater	great	JJR
cord-270934-vzsdvrwo	88	25	vigor	vigor	NN
cord-270934-vzsdvrwo	88	26	where	where	WRB
cord-270934-vzsdvrwo	88	27	a	a	DT
cord-270934-vzsdvrwo	88	28	larger	large	JJR
cord-270934-vzsdvrwo	88	29	scientific	scientific	JJ
cord-270934-vzsdvrwo	88	30	and	and	CC
cord-270934-vzsdvrwo	88	31	intellectual	intellectual	JJ
cord-270934-vzsdvrwo	88	32	investment	investment	NN
cord-270934-vzsdvrwo	88	33	is	be	VBZ
cord-270934-vzsdvrwo	88	34	needed	need	VBN
cord-270934-vzsdvrwo	88	35	towards	towards	IN
cord-270934-vzsdvrwo	88	36	early	early	JJ
cord-270934-vzsdvrwo	88	37	detection	detection	NN
cord-270934-vzsdvrwo	88	38	and	and	CC
cord-270934-vzsdvrwo	88	39	prevention	prevention	NN
cord-270934-vzsdvrwo	88	40	.	.	.
cord-270934-vzsdvrwo	89	1	The	the	DT
cord-270934-vzsdvrwo	89	2	pandemic	pandemic	NN
cord-270934-vzsdvrwo	89	3	,	,	,
cord-270934-vzsdvrwo	89	4	with	with	IN
cord-270934-vzsdvrwo	89	5	all	all	PDT
cord-270934-vzsdvrwo	89	6	its	-PRON-	PRP$
cord-270934-vzsdvrwo	89	7	terrifying	terrifying	JJ
cord-270934-vzsdvrwo	89	8	consequences	consequence	NNS
cord-270934-vzsdvrwo	89	9	,	,	,
cord-270934-vzsdvrwo	89	10	is	be	VBZ
cord-270934-vzsdvrwo	89	11	also	also	RB
cord-270934-vzsdvrwo	89	12	a	a	DT
cord-270934-vzsdvrwo	89	13	graphic	graphic	JJ
cord-270934-vzsdvrwo	89	14	reminder	reminder	NN
cord-270934-vzsdvrwo	89	15	of	of	IN
cord-270934-vzsdvrwo	89	16	something	something	NN
cord-270934-vzsdvrwo	89	17	beautiful	beautiful	JJ
cord-270934-vzsdvrwo	89	18	;	;	:
cord-270934-vzsdvrwo	89	19	the	the	DT
cord-270934-vzsdvrwo	89	20	oceanic	oceanic	JJ
cord-270934-vzsdvrwo	89	21	,	,	,
cord-270934-vzsdvrwo	89	22	global	global	JJ
cord-270934-vzsdvrwo	89	23	connection	connection	NN
cord-270934-vzsdvrwo	89	24	of	of	IN
cord-270934-vzsdvrwo	89	25	humanity	humanity	NN
cord-270934-vzsdvrwo	89	26	.	.	.
cord-270934-vzsdvrwo	90	1	Solutions	solution	NNS
cord-270934-vzsdvrwo	90	2	we	-PRON-	PRP
cord-270934-vzsdvrwo	90	3	seek	seek	VBP
cord-270934-vzsdvrwo	90	4	for	for	IN
cord-270934-vzsdvrwo	90	5	cancer	cancer	NN
cord-270934-vzsdvrwo	90	6	patients	patient	NNS
cord-270934-vzsdvrwo	90	7	must	must	MD
cord-270934-vzsdvrwo	90	8	be	be	VB
cord-270934-vzsdvrwo	90	9	universally	universally	RB
cord-270934-vzsdvrwo	90	10	applicable	applicable	JJ
cord-270934-vzsdvrwo	90	11	,	,	,
cord-270934-vzsdvrwo	90	12	because	because	IN
cord-270934-vzsdvrwo	90	13	"	"	``
cord-270934-vzsdvrwo	90	14	Any	any	DT
cord-270934-vzsdvrwo	90	15	man	man	NN
cord-270934-vzsdvrwo	90	16	's	's	POS
cord-270934-vzsdvrwo	90	17	death	death	NN
cord-270934-vzsdvrwo	90	18	diminishes	diminish	VBZ
cord-270934-vzsdvrwo	90	19	me	-PRON-	PRP
cord-270934-vzsdvrwo	90	20	/	/	.
cord-270934-vzsdvrwo	91	1	For	for	IN
cord-270934-vzsdvrwo	91	2	I	-PRON-	PRP
cord-270934-vzsdvrwo	91	3	am	be	VBP
cord-270934-vzsdvrwo	91	4	involved	involve	VBN
cord-270934-vzsdvrwo	91	5	in	in	IN
cord-270934-vzsdvrwo	91	6	mankind	mankind	NN
cord-270934-vzsdvrwo	91	7	/	/	.
cord-270934-vzsdvrwo	92	1	And	and	CC
cord-270934-vzsdvrwo	92	2	therefore	therefore	RB
cord-270934-vzsdvrwo	92	3	,	,	,
cord-270934-vzsdvrwo	92	4	never	never	RB
cord-270934-vzsdvrwo	92	5	send	send	VBP
cord-270934-vzsdvrwo	92	6	to	to	TO
cord-270934-vzsdvrwo	92	7	know	know	VB
cord-270934-vzsdvrwo	92	8	for	for	IN
cord-270934-vzsdvrwo	92	9	whom	whom	WP
cord-270934-vzsdvrwo	92	10	the	the	DT
cord-270934-vzsdvrwo	92	11	bell	bell	NNP
cord-270934-vzsdvrwo	92	12	tolls	toll	NNS
cord-270934-vzsdvrwo	93	1	/	/	NFP
cord-270934-vzsdvrwo	94	1	It	-PRON-	PRP
cord-270934-vzsdvrwo	94	2	tolls	toll	VBZ
cord-270934-vzsdvrwo	94	3	for	for	IN
cord-270934-vzsdvrwo	94	4	thee	thee	NN
cord-270934-vzsdvrwo	94	5	"	"	''
cord-270934-vzsdvrwo	95	1	(	(	-LRB-
cord-270934-vzsdvrwo	95	2	John	John	NNP
cord-270934-vzsdvrwo	95	3	Donne	Donne	NNP
cord-270934-vzsdvrwo	95	4	,	,	,
cord-270934-vzsdvrwo	95	5	Meditation	Meditation	NNP
cord-270934-vzsdvrwo	95	6	17	17	CD
cord-270934-vzsdvrwo	95	7	,	,	,
cord-270934-vzsdvrwo	95	8	Devotions	Devotions	NNPS
cord-270934-vzsdvrwo	95	9	upon	upon	IN
cord-270934-vzsdvrwo	95	10	Emergent	Emergent	NNP
cord-270934-vzsdvrwo	95	11	Occasions	Occasions	NNP
cord-270934-vzsdvrwo	95	12	)	)	-RRB-
cord-270934-vzsdvrwo	95	13	.	.	.
cord-270934-vzsdvrwo	96	1	Lenalidomide	Lenalidomide	NNP
cord-270934-vzsdvrwo	96	2	in	in	IN
cord-270934-vzsdvrwo	96	3	the	the	DT
cord-270934-vzsdvrwo	96	4	myelodysplastic	myelodysplastic	JJ
cord-270934-vzsdvrwo	96	5	syndrome	syndrome	NN
cord-270934-vzsdvrwo	96	6	with	with	IN
cord-270934-vzsdvrwo	96	7	chromosome	chromosome	NN
cord-270934-vzsdvrwo	96	8	5q	5q	CD
cord-270934-vzsdvrwo	96	9	deletion	deletion	NN
cord-270934-vzsdvrwo	97	1	Luspatercept	Luspatercept	NNP
cord-270934-vzsdvrwo	97	2	in	in	IN
cord-270934-vzsdvrwo	97	3	patients	patient	NNS
cord-270934-vzsdvrwo	97	4	with	with	IN
cord-270934-vzsdvrwo	97	5	lower	low	JJR
cord-270934-vzsdvrwo	97	6	-	-	HYPH
cord-270934-vzsdvrwo	97	7	risk	risk	NN
cord-270934-vzsdvrwo	97	8	myelodysplastic	myelodysplastic	JJ
cord-270934-vzsdvrwo	97	9	syndromes	syndrome	NNS
cord-270934-vzsdvrwo	97	10	COVID-19	covid-19	VBP
cord-270934-vzsdvrwo	97	11	and	and	CC
cord-270934-vzsdvrwo	97	12	acute	acute	JJ
cord-270934-vzsdvrwo	97	13	myeloid	myeloid	NN
cord-270934-vzsdvrwo	97	14	leukemia	leukemia	NN
cord-270934-vzsdvrwo	97	15	:	:	:
cord-270934-vzsdvrwo	98	1	Frequently	frequently	RB
cord-270934-vzsdvrwo	98	2	asked	ask	VBN
cord-270934-vzsdvrwo	98	3	questions	question	NNS
cord-270934-vzsdvrwo	98	4	(	(	-LRB-
cord-270934-vzsdvrwo	98	5	Version	version	NN
cord-270934-vzsdvrwo	98	6	1.1	1.1	CD
cord-270934-vzsdvrwo	98	7	Venetoclax	Venetoclax	NNP
cord-270934-vzsdvrwo	98	8	combined	combine	VBN
cord-270934-vzsdvrwo	98	9	with	with	IN
cord-270934-vzsdvrwo	98	10	decitabine	decitabine	NN
cord-270934-vzsdvrwo	98	11	or	or	CC
cord-270934-vzsdvrwo	98	12	azacitidine	azacitidine	NN
cord-270934-vzsdvrwo	98	13	in	in	IN
cord-270934-vzsdvrwo	98	14	treatment	treatment	NN
cord-270934-vzsdvrwo	98	15	-	-	HYPH
cord-270934-vzsdvrwo	98	16	naive	naive	JJ
cord-270934-vzsdvrwo	98	17	,	,	,
cord-270934-vzsdvrwo	98	18	elderly	elderly	JJ
cord-270934-vzsdvrwo	98	19	patients	patient	NNS
cord-270934-vzsdvrwo	98	20	with	with	IN
cord-270934-vzsdvrwo	98	21	acute	acute	JJ
cord-270934-vzsdvrwo	98	22	myeloid	myeloid	JJ
cord-270934-vzsdvrwo	98	23	leukemia	leukemia	NN
cord-270934-vzsdvrwo	98	24	Blood	blood	NN
cord-270934-vzsdvrwo	99	1	CPX-351	cpx-351	UH
cord-270934-vzsdvrwo	100	1	(	(	-LRB-
cord-270934-vzsdvrwo	100	2	cytarabine	cytarabine	NN
cord-270934-vzsdvrwo	100	3	and	and	CC
cord-270934-vzsdvrwo	100	4	daunorubicin	daunorubicin	NNS
cord-270934-vzsdvrwo	100	5	)	)	-RRB-
cord-270934-vzsdvrwo	100	6	liposome	liposome	NN
cord-270934-vzsdvrwo	100	7	for	for	IN
cord-270934-vzsdvrwo	100	8	injection	injection	NN
cord-270934-vzsdvrwo	100	9	versus	versus	IN
cord-270934-vzsdvrwo	100	10	conventional	conventional	JJ
cord-270934-vzsdvrwo	100	11	cytarabine	cytarabine	NN
cord-270934-vzsdvrwo	100	12	plus	plus	CC
cord-270934-vzsdvrwo	100	13	daunorubicin	daunorubicin	NNS
cord-270934-vzsdvrwo	100	14	in	in	IN
cord-270934-vzsdvrwo	100	15	older	old	JJR
cord-270934-vzsdvrwo	100	16	patients	patient	NNS
cord-270934-vzsdvrwo	100	17	with	with	IN
cord-270934-vzsdvrwo	100	18	newly	newly	RB
cord-270934-vzsdvrwo	100	19	diagnosed	diagnose	VBN
cord-270934-vzsdvrwo	100	20	secondary	secondary	JJ
cord-270934-vzsdvrwo	100	21	acute	acute	JJ
cord-270934-vzsdvrwo	100	22	myeloid	myeloid	NN
cord-270934-vzsdvrwo	100	23	leukemia	leukemia	NN
cord-270934-vzsdvrwo	100	24	Optimization	Optimization	NNP
cord-270934-vzsdvrwo	100	25	of	of	IN
cord-270934-vzsdvrwo	100	26	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	100	27	for	for	IN
cord-270934-vzsdvrwo	100	28	younger	young	JJR
cord-270934-vzsdvrwo	100	29	patients	patient	NNS
cord-270934-vzsdvrwo	100	30	with	with	IN
cord-270934-vzsdvrwo	100	31	acute	acute	JJ
cord-270934-vzsdvrwo	100	32	myeloid	myeloid	JJ
cord-270934-vzsdvrwo	100	33	leukemia	leukemia	NN
cord-270934-vzsdvrwo	100	34	:	:	:
cord-270934-vzsdvrwo	100	35	Results	result	NNS
cord-270934-vzsdvrwo	100	36	of	of	IN
cord-270934-vzsdvrwo	100	37	the	the	DT
cord-270934-vzsdvrwo	100	38	Medical	Medical	NNP
cord-270934-vzsdvrwo	100	39	Research	Research	NNP
cord-270934-vzsdvrwo	100	40	Council	Council	NNP
cord-270934-vzsdvrwo	101	1	AML15	aml15	DT
cord-270934-vzsdvrwo	101	2	trial	trial	NN
cord-270934-vzsdvrwo	102	1	Intensive	intensive	JJ
cord-270934-vzsdvrwo	102	2	postremission	postremission	NN
cord-270934-vzsdvrwo	103	1	chemotherapy	chemotherapy	NN
cord-270934-vzsdvrwo	103	2	in	in	IN
cord-270934-vzsdvrwo	103	3	adults	adult	NNS
cord-270934-vzsdvrwo	103	4	with	with	IN
cord-270934-vzsdvrwo	103	5	acute	acute	JJ
cord-270934-vzsdvrwo	103	6	myeloid	myeloid	NN
cord-270934-vzsdvrwo	103	7	leukemia	leukemia	NN
cord-270934-vzsdvrwo	103	8	Retinoic	Retinoic	NNP
cord-270934-vzsdvrwo	103	9	acid	acid	NN
cord-270934-vzsdvrwo	103	10	and	and	CC
cord-270934-vzsdvrwo	103	11	arsenic	arsenic	NN
cord-270934-vzsdvrwo	103	12	trioxide	trioxide	NN
cord-270934-vzsdvrwo	103	13	for	for	IN
cord-270934-vzsdvrwo	103	14	acute	acute	JJ
cord-270934-vzsdvrwo	103	15	promyelocytic	promyelocytic	JJ
cord-270934-vzsdvrwo	103	16	leukemia	leukemia	NN
cord-270934-vzsdvrwo	104	1	Interim	interim	JJ
cord-270934-vzsdvrwo	104	2	guidelines	guideline	NNS
cord-270934-vzsdvrwo	104	3	for	for	IN
cord-270934-vzsdvrwo	104	4	COVID-19	covid-19	JJ
cord-270934-vzsdvrwo	104	5	management	management	NN
cord-270934-vzsdvrwo	104	6	in	in	IN
cord-270934-vzsdvrwo	104	7	hematopoietic	hematopoietic	JJ
cord-270934-vzsdvrwo	104	8	cell	cell	NN
cord-270934-vzsdvrwo	104	9	transplant	transplant	NN
cord-270934-vzsdvrwo	104	10	and	and	CC
cord-270934-vzsdvrwo	104	11	cellular	cellular	JJ
cord-270934-vzsdvrwo	104	12	therapy	therapy	NN
cord-270934-vzsdvrwo	104	13	patients	patient	NNS
cord-270934-vzsdvrwo	105	1	(	(	-LRB-
cord-270934-vzsdvrwo	105	2	Version	version	NN
cord-270934-vzsdvrwo	105	3	1.2	1.2	CD